Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Surveillance for Cancer Incidence and Mortality — United States, 2011

Simple D. Singh, MD

S. Jane Henley, MSPH

A. Blythe Ryerson, PhD

Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC


Corresponding author: Simple Singh, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC. Telephone: 770-488-4292; e-mail: sdsingh@cdc.gov.

Preface

This report provides, in tabular and graphic form, official federal statistics on the occurrence of cancer for 2011 and trends for 1999–2011 as reported by CDC and the National Cancer Institute (NCI) (1). Cancer incidence data are from population-based cancer registries that participate in CDC's National Program of Cancer Registries (NPCR) and NCI's Surveillance, Epidemiology, and End Results (SEER) program reported as of November 2013. Cancer mortality data are from death certificate information reported to state vital statistics offices through 2011 and compiled into a national file for the entire United States by CDC's National Center for Health Statistics' (NCHS) National Vital Statistics System (NVSS). This report is a part of the first-ever Summary of Notifiable Noninfectious Conditions and Disease Outbreaks, which encompasses various surveillance years but is being published in 2015 (2). The Summary of Notifiable Noninfectious Conditions and Disease Outbreaks appears in the same volume of MMWR as the annual Summary of Notifiable Infectious Diseases (3).

This report presents information on new cancer cases and deaths for 2011. The number and rate of cancer cases and deaths are stratified by the primary cancer sites as reported for 2011; information is provided by demographic characteristic (e.g., sex, age, race, and ethnicity) and primary cancer site (68 selected sites among men and 72 selected sites among women) (Tables 112). Age-adjusted cancer incidence and death rates for the most common sites are shown by race, sex, and ethnicity for 2011, the most recent diagnosis year (Figure 1). Maps of the United States display age-adjusted cancer incidence and death rates, presented by quartiles, for 2011, the most recent diagnosis year (Figures 2 and 3). Time trends in age-adjusted cancer incidence and death rates during 1999–2011 are shown for all sites combined by race, sex, and ethnicity (Figures 47). Age-adjusted cancer incidence and death rates are shown by primary site and year for the period 1999–2011 (Tables 1316).

Background

Cancer comprises a diverse mix of diseases occurring in every part of the body and is a leading cause of death in the United States, second only to heart disease (4). More than half of cancer cases could be prevented (5). Surveillance of cancer incidence and mortality can help public health officials target areas for control efforts (6) and track progress toward meeting the national health objectives set forth in Healthy People 2020 (7). Because cancer is a reportable disease in every state, hospitals, physician's offices, pathology laboratories, and other medical facilities are required to submit data on all cancer diagnoses to a central cancer registry at the state or territorial level. A cancer registry is a database that contains individual records of all cancer cases in a defined population and includes patient demographics, tumor characteristics (e.g., cancer site and pathology), and information about the notifying health provider or facility. In 1992, Congress established NPCR by enacting the Cancer Registries Amendment Act, Public Law 102-515 (8). Administered by CDC, NPCR collects data on the occurrence of cancer, and the type, extent, and location of the cancer. Before NPCR was established, 10 states had no registry, and most states with registries lacked the resources and state legislation needed to gather complete data (9). Presently, NPCR supports central cancer registries in 45 states, the District of Columbia, Puerto Rico, and the U.S. Pacific Island Jurisdictions. NPCR data represent 96% of the overall U.S. population. Together, NPCR and NCI's SEER Program collect data for the entire U.S. population. Cancer control planners and others can identify variations in cancer rates by population subgroups and monitor trends over time to guide the planning and evaluation of cancer prevention and control programs and allocation of health resources.

Data Sources

Data about cancer incidence and mortality in the Summary (Noninfectious) come from the official federal statistics on cancer, the U.S. Cancer Statistics (USCS) dataset (1). The USCS dataset includes cancer incidence data from NPCR registries in 45 states and the District of Columbia (cancer incidence data from Puerto Rico and the U.S. Pacific Island Jurisdictions were not available for this analysis) and SEER program registries in the remaining five states (Connecticut, Hawaii, Iowa, New Mexico, and Utah) and cancer mortality data from NVSS.

Incidence Data

The primary source of data on cancer incidence is medical records. Staff at health care facilities abstract data from patients' medical records, enter it into the facility's own cancer registry if it has one, and then send the data to the regional or state registry. Both NPCR and SEER registries collect data using uniform data items and codes as documented by the North American Association of Central Cancer Registries (NAACCR). This uniformity ensures that data items collected by the two federal programs are comparable (10,11). Information on primary site and histology is coded according to the International Classification of Diseases for Oncology, Third Edition (ICD-O-3) and categorized according to the revised SEER recodes dated January 27, 2003, which define standard groupings of primary cancer sites (http://seer.cancer.gov/siterecode) (12). Beginning with 2010 diagnoses, cases were first classified by anatomic site using ICD-O-3; cases with hematopoetic histologies were further classified by using the 2008 WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (13). Data from the NPCR registries provided in this report were reported to CDC as of November 30, 2013. Data from SEER registries were reported to NCI as of November 1, 2013.

NPCR and SEER cancer registries consider as reportable all incident cases with a behavior code of 2 (in situ, noninvasive) or 3 (invasive, primary site only) in ICD-O-3, except for in situ cancer of the cervix. Basal and squamous cell carcinomas of the skin also are excluded, except for those on the skin of the genital organs. (12). Several cancers that are coded as malignant in ICD-O-3 (beginning with 2001 diagnoses) were not coded as malignant in ICD-O-2 (10). Additional information is provided in the USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes/data_sources/incidence.htm).

Mortality Data

Cancer mortality statistics are based on information from all death certificates filed in the 50 states and the District of Columbia and processed by NVSS at NCHS (14). The cancer mortality data were compiled in accordance with World Health Organization regulations, which specify that member nations classify and code causes of death in accordance with the current revision of the International Classification of Diseases (ICD) (15). For consistency with the data on cancer incidence, the cancer sites in mortality data were grouped according to the revised SEER recodes dated January 27, 2003 (available at http://seer.cancer.gov/codrecode). Additional information is provided in the USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes/data_sources/mortality.htm).

Population Estimates

Population denominators are race-specific, ethnicity-specific, and sex-specific county population estimates from the 2010 U.S. Census, modified by SEER and aggregated to the state and national level. Additional details about SEER are available at http://seer.cancer.gov/popdata/index.html.

Interpreting Data

Incidence Data

Each year, state cancer registries submit cancer cases for a new diagnosis year and an updated version of the previous years' cancer cases to CDC or NCI. Therefore, each year when U.S. Cancer Statistics is published, updates to the previous year's data are published, using the most recent data submission and the most recent population data. Users of cancer incidence data published by federal agencies should be mindful of the data submission dates for all data used in their analyses.

Mortality Data

Cancer mortality statistics in USCS are influenced by the accuracy of information on the death certificate. Unlike incidence data, mortality data for a calendar year are not updated after the data file is released. Mortality data for the entire United States refer to only deaths that occurred within the United States; data for geographic areas are provided by the decedent's place of residence.

Race and Ethnicity Data

For cancer incidence, race and ethnicity data are abstracted from medical records and grouped into categories (11). When reporting cancer mortality, race and Hispanic origin are recorded separately on the death certificate by the funeral director as provided by an informant or, in the absence of an informant, on the basis of observation (16).

Differences in rates among racial and ethnic (Hispanic origin) populations should be interpreted with caution. A recent study using SEER incidence data suggests that the quality of data on race in cancer registries is considered excellent for whites, blacks, and Asians/Pacific Islanders, good for Hispanics, and poor for American Indians/Alaska Natives (17). Recent studies involving cancer mortality data demonstrate that death rates for whites and blacks generally are estimated accurately whereas death rates for Asians/Pacific Islanders, American Indians/Alaska Natives, and Hispanics are underestimated (18). For this reason, incidence and mortality data provided in this report might be underestimated for these groups, possibly because of misclassification of race or Hispanic ethnicity.

Four NPCR registries (Delaware, Kentucky, Missouri, and South Carolina) opted not to present state-specific Asian/Pacific Islander counts and rates. Six NPCR registries (Delaware, Kentucky, Massachusetts, Missouri, Pennsylvania, and South Carolina) opted not to present state-specific Hispanic (classified by the NAACCR Hispanic Identification [NHIA] Algorithm) counts and rates. Nine NPCR registries (Delaware, Georgia, Illinois, Kansas, Kentucky, Missouri, New Jersey, New York, and South Carolina) opted not to present state-specific American Indian/Alaska Native counts and rates. However, in each of these cases, the aggregate national rates presented in this report include data for these registries.

Methods for Identifying Cancer

Medical facilities such as hospitals, doctor's offices, and pathology laboratories send information about cancer cases to their cancer registry. Most information comes from hospitals, where highly trained cancer registrars transfer the information from the patient's medical record to the registry's computer software using standardized codes. The data are then sent to the central cancer registry. Every year the central cancer registries electronically submit incidence, demographic, and clinical data to NPCR or SEER.

Population Coverage

The population coverage for incidence data varies by diagnosis year. Population coverage might be affected by the suppression of state incidence data, if a state did not meet the publication criteria or did not submit data. In addition, state incidence data might be suppressed if <16 cases were reported or if the state requested that the data be suppressed. Additional information is provided by the USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_pop_coverage.htm). Mortality data from malignant neoplasms (i.e., cancers) as recorded in the NVSS from the 50 states and the District of Columbia are available in USCS, and thus 100% of the U.S. population is covered each year.

Suppression of Rates and Counts

When the numbers of cases or deaths used to compute rates are small, those rates tend to have poor reliability. Therefore, in an effort to discourage misinterpretation or use of rates or counts that are unstable because case or death counts are small, incidence and death rates and counts of <16 are not shown in tables and figures. The use of a threshold value for suppressing cells helps protect the confidentiality of patients by reducing or eliminating the risk for disclosure of their identity. Additional information is provided in the USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes/stat_methods/suppression.htm).

Publication Criteria

Cancer incidence data that appear in this report are derived from state cancer registries that have high-quality cancer incidence data for individual (e.g., 2011) and combined (e.g., 1999–2011) years as demonstrated by meeting all of the following criteria on data quality for all cancer sites combined:

  • case ascertainment is ≥90% (margin of error ±5%) complete,
  • ≤5% of cases are ascertained solely on the basis of a death certificate,
  • ≤3% of cases are missing information on sex,
  • ≤3% of cases are missing information on age,
  • ≤5% of cases are missing information on race, and
  • ≥97% of the registry's records passed a set of single-field and inter-field computerized edits that test the validity and logic of data components.

Additional information about USCS is available at available at http://www.cdc.gov/uscs.

Highlights

Incidence and Death Rates

In 2011, approximately 1.5 million invasive cancers were diagnosed in the United States, an annual incidence rate of 451 cases per 100,000 persons. In the same year, approximately 576,000 persons died of cancer nationally, an annual death rate of 169 deaths per 100,000 persons. Differing rates of cancer by race, ethnicity, and state of residence indicate that for some populations, Healthy People 2020 objectives have already been achieved, whereas objectives for other populations have not been met, and these populations might benefit from targeted cancer prevention and control efforts.

Cancer incidence and death rates increase with age. In 2011, among persons in the youngest age group (<15 years), 10,063 new cancer cases (rate: 17 cases per 100,000 persons) and 1,283 cancer deaths (rate: two deaths per 100,000 persons) were reported. Among persons aged ≥65 years, 822,548 new cancer cases (rate: 2,005 cases per 100,000 persons) and 397,106 cancer deaths (rate: 960 deaths per 100,000 persons) were reported. Overall, 54% of cancer cases and 69% of cancer deaths in 2011 occurred among persons aged ≥65 years.

Among men in 2011, blacks had the highest cancer incidence and death rates in the United States, and American Indians/Alaska Natives and Asians/Pacific Islanders had the lowest cancer incidence and death rates. Among women in 2011, whites had the highest cancer incidence rates and blacks had the highest cancer death rates. American Indians/Alaska Natives had the lowest cancer incidence rates, and Asians/Pacific Islanders had the lowest cancer death rates. Differences in cancer rates by race and ethnicity might reflect differences in risk factors, screening, and treatment although rates among some populations might be underestimated because of problems ascertaining race or ethnicity. By state, overall (all cancer sites combined) cancer incidence rates in 2011 ranged from 374 to 509 cases per 100,000 persons, and overall cancer death rates ranged from 126 to 201 deaths per 100,000 persons.

Four cancer sites accounted for half of all cases diagnosed in 2011, including 209,292 prostate cancers, 220,097 female breast cancers, 207,339 lung and bronchus cancers (110,322 among men and 97,017 among women), and 135,260 colon and rectum cancers (70,099 among men and 65,161 among women). These four sites also accounted for half of cancer deaths in 2011, including 156,953 lung cancer deaths, 51,783 colon and rectum cancer deaths, 40,931 female breast cancer deaths, and 27,970 prostate cancer deaths.

Time Trends in Incidence and Death Rates

On the basis of data from registries meeting data quality criteria during 1999–2011, cancer incidence rates declined from 485 cancer cases per 100,000 population in 1999 to 444 cases in 2011. Although lung cancer incidence declined steadily among men from 1999 to 2011, it increased among women from 1999 to 2005 and has since declined from 2005 to 2011. Prostate cancer incidence declined from 170 cases per 100,000 men in 1999 to 128 cases in 2011. Colorectal cancer incidence declined from 57 cases per 100,000 persons in 1999 to 40 cases in 2011. Female breast cancer incidence declined from 135 cases per 100,000 women in 1999 to 121 cases in 2005, increased to 125 cases in 2009, and declined again to 122 cases in 2011. During 1999–2011, cancer death rates declined from 201 deaths per 100,000 persons in 1999 to 169 deaths in 2011; during the same period, death rates declined for each of the top four cancers.

National cancer surveillance data help public health officials track progress toward achieving the national cancer objectives set forth in Healthy People 2020 (19). For the national cancer burden to be reduced and Healthy People 2020 targets to be met, behavioral and environmental factors that increase cancer risk must be reduced, and high-quality screening services and evidence-based treatments must be available and accessible to all persons. Several effective primary and secondary prevention measures, such as vaccination against infectious agents that cause cancer (i.e., hepatitis B virus and human papilloma virus), help with smoking cessation, and cancer screening, when effectively implemented and sustained, could reduce the number of new cancer cases and prevent many cancer-related deaths (20). Evidence-based interventions can be implemented at both the individual level and the population level to reduce cancer risk factors, promote healthy living, and encourage cancer screening (5).

Acknowledgment

Data were provided by state and regional cancer registry personnel.

References

  1. US Cancer Statistics Working Group. United States cancer statistics: 1999–2011. Incidence and mortality web-based report. Atlanta, GA: US Department of Health and Human Services, CDC, National Cancer Institute; 2014.
  2. CDC. Summary of notifiable noninfectious conditions and disease outbreaks—United States. MMWR Morb Mortal Wkly Rep 2013;62(54).
  3. CDC. Summary of notifiable infectious diseases—United States. MMWR Morb Mortal Wkly Rep 2013;62(53).
  4. Heron M. Deaths: leading causes for 2010. Natl Vital Stat Rep 2013;62(6). Available at http://www.cdc.gov/nchs/data/nvsr/nvsr62/nvsr62_06.pdf.
  5. Colditz GA, Wolin KY, Gehlert S. Applying what we know to accelerate cancer prevention. Sci Transl Med 2012;4:127rv124.
  6. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. JNCI 2003;95:1276–99.
  7. US Department of Health and Human Services. Healthy people 2020. Washington, DC: US Department of Health and Human Services; 2015. Available at http://www.healthypeople.gov/2020/topicsobjectives2020/default.aspx.
  8. Fisher R, Haenlein M. Legislative authorizations for cancer registries. In: National Cancer Institute, National Institutes of Health. State cancer legislative database update. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health. National Cancer Institute; 1991:8–15.
  9. CDC. State cancer registries: status of authorizing legislation and enabling regulations—United States, October 1993. MMWR Morb Mort Wkly Rep 1994;43:71–5.
  10. Fritz A RL. The SEER Program Code Manual. Bethesda, MD: National Cancer Institute; 1998.
  11. Havener L TM, eds. Standards for cancer registries volume ii: data standards and data dictionary. 13th ed. Version 11.3. Springfield, IL: North American Association of Central Cancer Registries; 2008.
  12. Fritz A, Percy C, Jack A. International classification of diseases of oncology. Geneva, Switzerland: World Health Organization; 2000.
  13. National Cancer Institute. Hematopoietic codes based on WHO classification of tumours of haematopoietic and lymphoid tissues. Rockville, MD: US Department of Health and Human Services, National Cancer Institute; 2008. Available at http://seer.cancer.gov/iccc.
  14. Hetzel AM. U.S. Vital Statistics System: major activities and developments, 1950–95. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics; 1997. PHS 97-1993. Available at http://www.cdc.gov/nchs/data/misc/usvss.pdf.
  15. World Health Organization. International statistical classification of diseases and related health problems. 10th revision. Geneva, Switzerland: World Health Organization; 1992.
  16. Miniño AM, Heron MP, Smith BL, Kochanek K. Deaths: final data for 2004. Natl Vital Stat Rep 2007;55(19).
  17. Clegg LX, Reichman ME, Hankey BF, et al. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes & Control: CCC 2007;18:177–87.
  18. Arias E, Schauman W, Eschbach K, Sorlie P. The validity of race and Hispanic origin reporting on death certificates in the United States. Vital Health Stat 2008;2(148).
  19. Henley SJ, Singh S, King J, et al. Invasive cancer incidence—United States, 2010. MMWR Morb Mort Wkly Rep 2014;6:253–9.
  20. Agency for Healthcare Research and Quality. The guide to clinical preventive services, 2014. Rockville, MD: Agency for Healthcare Research and Quality; 2014. Available at http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/guide/index.html.

FIGURE 1. Reported rate* of invasive cancer cases for most common cancer sites, by sex and race/ethnicity§ — United States, 2011

The figure presents ten bar charts showing the age-adjusted rate per 100,000 population for 2011 for three types of invasive cancer — breast, lung and bronchus, and rectum — by sex and race/ethnicity. Data are drawn from CDC’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results program.

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander.

Sources: CDC's National Program of Cancer Registries and the National Cancer Institute's Surveillance, Epidemiology, and End Results program.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.

§ Race categories are not mutually exclusive from Hispanic origin. Rates are not presented for persons of unknown or other race. Data for specified racial or ethnic populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes/interpreting/race.htm).

Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (covering approximately 99% of the U.S. population). Registry-specific data quality information is available at http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_data_quality.htm. Caution should be used when comparing incidence and death rates because of the difference in population coverage.

Alternate Text: The figure presents ten bar charts showing the age-adjusted rate per 100,000 population for 2011 for three types of invasive cancer — breast, lung and bronchus, and rectum — by sex and race/ethnicity. Data are drawn from CDC’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results program.


FIGURE 2. Reported rate* of invasive cancer cases, by primary cancer site and state — United States, 2011§

This figure presents six maps of the United States showing the age-adjusted rate per 100,000 persons of invasive cancer cases for 2011 by primary cancer site for all cancer sites combined, female breast, lung, prostate, cervix uteri, and colon and rectum. The number of cases varies by state.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.

§ Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (covering approximately 99% of the U.S. population). Registry-specific data quality information is available at http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_data_quality.htm. Caution should be used when comparing incidence and death rates because of potential differences in population coverage.

Alternate Text: This figure presents six maps of the United States showing the age-adjusted rate per 100,000 persons of invasive cancer cases for 2011 by primary cancer site for all cancer sites combined, female breast, lung, prostate, cervix uteri, and colon and rectum. The number of cases varies by state.


FIGURE 3. Rate* of cancer deaths, by primary cancer site and state — United States, 2011

This figure presents six maps of the United States showing the age-adjusted rate per 100,000 persons of cancer deaths for 2011 by primary cancer site for all cancer sites combined, female breast, lung, prostate, cervix uteri, and colon and rectum. The number of cases varies by state.

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS Technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Data are from the National Vital Statistics System (NVSS). Data for death rates cover 100% of the U.S. population. Caution should be used when comparing incidence and death rates because of potential differences in population coverage.

Alternate Text: This figure presents six maps of the United States showing the age-adjusted rate per 100,000 persons of cancer deaths for 2011 by primary cancer site for all cancer sites combined, female breast, lung, prostate, cervix uteri, and colon and rectum. The number of cases varies by state.


FIGURE 4. Reported rate* of invasive cancer cases by primary cancer site, race, § and sex — United States, 1999–2011

This figure presents 11 line charts showing, by race and sex, the age-adjusted rate per 100,000 persons of invasive cancer cases in the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by race for male prostate cancer and female breast cancer.

Alternate Text: This figure presents 11 line charts showing, by race and sex, the age-adjusted rate per 100,000 persons of invasive cancer cases in the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by race for male prostate cancer and female breast cancer.


FIGURE 4. (Continued) Reported rate* of invasive cancer cases by primary cancer site, race,§ and sex — United States, 1999–2011

This figure presents 11 line charts showing, by race and sex, the age-adjusted rate per 100,000 persons of invasive cancer cases in the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by race for male prostate cancer and female breast cancer.

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.

§ Rates are not presented for persons of unknown or other race. Data for specified racial populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes/interpreting/race.htm).

Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined for all years, 1999–2011 (covering approximately 89% of the U.S. population). See registry-specific data quality information for all years, 1999–2011 (http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_data_quality.htm). Caution should be used when comparing incidence and death rates because of potential differences in population coverage.

Alternate Text: This figure presents 11 line charts showing, by race and sex, the age-adjusted rate per 100,000 persons of invasive cancer cases in the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by race for male prostate cancer and female breast cancer.


FIGURE 5. Reported rate* of invasive cancer cases, by primary cancer site, ethnicity,§ and sex — United States, 1999–2011

This figure presents 11 line charts showing, by ethnicity (Hispanic and non-Hispanic) and sex, the age-adjusted rate per 100,000 population of invasive cancer cases in the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by etnicity for male prostate cancer and female breast cancer.

Alternate Text: This figure presents 11 line charts showing, by ethnicity (Hispanic and non-Hispanic) and sex, the age-adjusted rate per 100,000 population of invasive cancer cases in the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by etnicity for male prostate cancer and female breast cancer.


FIGURE 5. (Continued) Reported rate* of invasive cancer cases, by primary cancer site, ethnicity,§ and sex — United States, 1999–2011

This figure presents 11 line charts showing, by ethnicity (Hispanic and non-Hispanic) and sex, the age-adjusted rate per 100,000 population of invasive cancer cases in the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by etnicity for male prostate cancer and female breast cancer.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.

§ Data for specified ethnic populations should be interpreted with caution. For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes/interpreting/race.htm).

Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined for all years, 1999–2011 (covering approximately 89% of the U.S. population). See registry-specific data quality information for all years, 1999–2011(http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_data_quality.htm). Caution should be used when comparing incidence and death rates because of potential differences in population coverage.

Alternate Text: This figure presents 11 line charts showing, by ethnicity (Hispanic and non-Hispanic) and sex, the age-adjusted rate per 100,000 population of invasive cancer cases in the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by etnicity for male prostate cancer and female breast cancer.


FIGURE 6. Reported rate* of cancer deaths, by primary cancer site, race, and sex — United States, 1999–2011§

The figure presents 11 line charts showing, by race and sex, age-adjusted death rates per 100,000 population for the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by race for male prostate cancer and female breast cancer.

Alternate Text: The figure presents 11 line charts showing, by race and sex, age-adjusted death rates per 100,000 population for the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by race for male prostate cancer and female breast cancer.


FIGURE 6. (Continued) Reported rate* of cancer deaths, by primary cancer site, race, and sex — United States, 1999–2011§

The figure presents 11 line charts showing, by race and sex, age-adjusted death rates per 100,000 population for the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by race for male prostate cancer and female breast cancer.

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander.

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Rates are not presented for persons of unknown or other race. Data for specified racial populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes/interpreting/race.htm).

§ Data are from the National Vital Statistics System (NVSS). Data for death rates cover 100% of the U.S. population. Caution should be used when comparing incidence and death rates because of potential differences in population coverage.

Alternate Text: The figure presents 11 line charts showing, by race and sex, age-adjusted death rates per 100,000 population for the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by race for male prostate cancer and female breast cancer.


FIGURE 7. Reported cancer death rates* by primary cancer site, ethnicity, and sex — United States, 1999–2011

The figure presents 11 line charts showing, by ethnicity (Hispanic and non-Hispanic) and sex, age-adjusted death rates per 100,000 population for the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by ethnicity for male prostate cancer and female breast cancer.

Alternate Text: The figure presents 11 line charts showing, by ethnicity (Hispanic and non-Hispanic) and sex, age-adjusted death rates per 100,000 population for the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by ethnicity for male prostate cancer and female breast cancer.


FIGURE 7. (Continued) Reported cancer death rates* by primary cancer site, ethnicity, and sex — United States, 1999–2011§

The figure presents 11 line charts showing, by ethnicity (Hispanic and non-Hispanic) and sex, age-adjusted death rates per 100,000 population for the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by ethnicity for male prostate cancer and female breast cancer.

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Data for specified ethnic populations should be interpreted with caution. For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes/interpreting/race.htm).

§ Data are from the National Vital Statistics System (NVSS). Data for death rates cover 100% of the U.S. population. Caution should be used when comparing incidence and death rates because of potential differences in population coverage.

Alternate Text: The figure presents 11 line charts showing, by ethnicity (Hispanic and non-Hispanic) and sex, age-adjusted death rates per 100,000 population for the United States during 1999–2011. Rates are shown for males and females combined and separately for each sex for all cancer sites combined, colorectal cancer, and lung and bronchus cancer, and by ethnicity for male prostate cancer and female breast cancer.


TABLE 1. Reported number and rate* of invasive cancer cases, by primary cancer site — United States, 2011§

Cancer site

All races/ethnicities

No.

Rate

All sites combined

1,532,066

450.6

Oral cavity and pharynx

39,152

11.2

Lip

1,997

0.6

Tongue

11,825

3.4

Salivary gland

3,995

1.2

Floor of mouth

1,945

0.5

Gum and other mouth

5,256

1.5

Nasopharynx

1,732

0.5

Tonsil

7,242

2.0

Oropharynx

1,822

0.5

Hypopharynx

2,302

0.7

Other oral cavity and pharynx

1,036

0.3

Digestive system

269,319

78.9

Esophagus

15,914

4.6

Stomach

22,424

6.6

Small intestine

7,686

2.2

Colon and rectum

135,260

39.9

Colon excluding rectum

96,970

28.7

Rectum and rectosigmoid junction

38,290

11.2

Anus, anal canal, and anorectum

6,067

1.8

Liver and intrahepatic bile duct

26,097

7.3

Gallbladder

3,778

1.1

Other biliary

5,926

1.8

Pancreas

41,473

12.2

Retroperitoneum

1,258

0.4

Peritoneum, omentum, and mesentery

1,923

0.6

Other digestive organs

1,513

0.4

Respiratory system

222,399

65.4

Nose, nasal cavity, and middle ear

2,166

0.6

Larynx

12,253

3.5

Lung and bronchus

207,339

61.0

Pleura

98

0

Trachea, mediastinum, and other respiratory organs

543

0.2

Bones and joints

2,889

0.9

Soft tissue including heart

10,385

3.2

Skin excluding basal and squamous

70,853

21.3

Melanoma of the skin

65,647

19.7

Other nonepithelial skin

5,206

1.6

Male and female breast

222,175

65.6

Female breast

220,097

122.0

Male breast

2,078

1.4


TABLE 1. (Continued) Reported number and rate* of invasive cancer cases, by primary cancer site — United States, 2011§

Cancer site

All races/ethnicities

No.

Rate

Female genital system

88,068

48.4

Cervix

12,109

7.5

Corpus and uterus, NOS

47,537

25.4

Corpus

45,994

24.6

Uterus, NOS

1,543

0.8

Ovary

20,593

11.3

Vagina

1,255

0.7

Vulva

4,596

2.5

Other female genital organs

1,978

1.1

Male genital system

218,876

134.8

Prostate

209,292

128.3

Testis

7,941

5.3

Penis

1,293

0.9

Other male genital organs

350

0.2

Urinary system

124,095

36.6

Urinary bladder

68,070

20.2

Kidney and renal pelvis

53,185

15.6

Ureter

1,862

0.6

Other urinary organs

978

0.3

Eye and orbit

2,511

0.8

Brain and other nervous system

21,084

6.4

Brain

19,818

6.0

Cranial nerves other nervous system

1,266

0.4

Endocrine system

46,586

14.5

Thyroid

44,332

13.8

Other endocrine including thymus

2,254

0.7

Lymphomas

70,861

21.3

Hodgkin lymphoma

8,416

2.7

Non-Hodgkin lymphoma

62,445

18.6

Myeloma

20,696

6.1

Leukemias

42,836

13.0

Acute lymphocytic leukemia

4,988

1.7

Chronic lymphocytic leukemia

13,947

4.1

Acute myeloid leukemia

13,093

4.0

Chronic myeloid leukemia

5,375

1.6

Other leukemia

5,433

1.6

Mesothelioma

3,229

1.0

Kaposi Sarcoma

1,154

0.4

Miscellaneous

54,898

16.3

Abbreviation: NOS = not otherwise specified.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.

§ Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (covering approximately 99% of the U.S. population). Registry-specific data quality information is available at http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_data_quality.htm.


TABLE 2. Reported number and rate* of cancer deaths, by primary cancer site — United States, 2011

Cancer site

All races/ethnicities

No.

Rate

All sites combined

576,685

168.7

Oral cavity and pharynx

8,657

2.5

Lip

83

0

Tongue

2,089

0.6

Salivary gland

820

0.2

Floor of mouth

84

0

Gum and other mouth

1,245

0.4

Nasopharynx

630

0.2

Tonsil

842

0.2

Oropharynx

861

0.2

Hypopharynx

322

0.1

Other oral cavity and pharynx

1,681

0.5

Digestive system

144,007

41.8

Esophagus

14,446

4.2

Stomach

11,035

3.3

Small intestine

1,256

0.4

Colon and rectum

51,783

15.1

Colon excluding rectum

42,181

12.3

Rectum and rectosigmoid junction

9,602

2.8

Anus, anal canal, and anorectum

863

0.2

Liver and intrahepatic bile duct

21,608

6.1

Gallbladder

2,101

0.6

Other biliary

1,510

0.4

Pancreas

37,344

10.9

Retroperitoneum

219

0.1

Peritoneum, omentum, and mesentery

807

0.2

Other digestive organs

1,035

0.3

Respiratory system

161,376

47.3

Nose, nasal cavity, and middle ear

416

0.1

Larynx

3,732

1.1

Lung and bronchus

156,953

46.0

Pleura

61

0

Trachea, mediastinum, and other respiratory organs

214

0.1

Bones and joints

1,423

0.4

Soft tissue including heart

4,408

1.3

Skin excluding basal and squamous

12,212

3.6

Melanoma of the skin

9,128

2.7

Other nonepithelial skin

3,084

0.9


TABLE 2. (Continued) Reported number and rate* of cancer deaths, by primary cancer site — United States, 2011

Cancer site

All races/ethnicities

No.

Rate

Male and female breast

41,374

12.0

Female breast

40,931

21.5

Male breast

443

0.3

Female genital system

29,027

15.3

Cervix

4,092

2.3

Corpus and Uterus, NOS

8,641

4.5

Corpus

3,714

1.9

Uterus, NOS

4,927

2.6

Ovary

14,346

7.5

Vagina

428

0.2

Vulva

1,022

0.5

Other female genital organs

498

0.3

Male genital system

28,630

21.2

Prostate

27,970

20.8

Testis

380

0.3

Penis

239

0.2

Other male genital organs

41

0

Urinary system

29,317

8.6

Urinary bladder

15,014

4.4

Kidney and renal pelvis

13,559

3.9

Ureter

338

0.1

Other urinary organs

406

0.1

Eye and orbit

280

0.1

Brain and other nervous system

14,491

4.3

Endocrine system

2,689

0.8

Thyroid

1,747

0.5

Other endocrine including thymus

942

0.3

Lymphomas

21,485

6.4

Hodgkin lymphoma

1,168

0.4

Non-Hodgkin lymphoma

20,317

6.0

Myeloma

11,411

3.4

Leukemias

23,194

6.9

Acute lymphocytic leukemia

1,432

0.4

Chronic lymphocytic leukemia

4,608

1.4

Acute myeloid leukemia

9,491

2.8

Chronic myeloid leukemia

1,091

0.3

Other leukemia

6,572

2.0

Mesothelioma

2,651

0.8

Miscellaneous

40,002

11.7

Abbreviation: NOS = not otherwise specified.

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see UCSC technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Data are from the National Vital Statistics System (NVSS).


TABLE 3. Reported number and rate* of invasive cancer cases, all cancer sites combined, by geographic division and area — United States, 2011§

Division/Area

All races/ethnicities

No.

Rate

Northeast

316,905

489.2

New England

82,141

480.0

Connecticut

20,368

483.2

Maine

8,254

479.3

Massachusetts

36,555

480.5

New Hampshire

7,704

494.0

Rhode Island

5,754

465.7

Vermont

3,506

453.9

Middle Atlantic

234,764

492.6

New Jersey

48,050

480.5

New York

108,554

494.2

Pennsylvania

78,160

498.5

Midwest

349,805

462.1

East North Central

241,710

461.2

Illinois

65,309

473.4

Indiana

31,791

445.4

Michigan

54,134

472.2

Ohio

60,357

448.3

Wisconsin

30,119

460.0

West North Central

108,095

464.3

Iowa

17,183

474.9

Kansas

14,572

466.5

Minnesota

28,835

491.1

Missouri

30,616

443.8

Nebraska

8,975

442.5

North Dakota

3,600

454.9

South Dakota

4,314

455.2

South

559,650

440.5

South Atlantic

306,473

440.5

Delaware

5,300

496.8

District of Columbia

3,088

509.3

Florida

106,062

426.4

Georgia

44,206

460.4

Maryland

27,802

438.6

North Carolina

49,065

460.7

South Carolina

23,234

434.8

Virginia

36,355

418.4

West Virginia

11,361

477.9


TABLE 3. (Continued) Reported number and rate* of invasive cancer cases, all cancer sites combined, by geographic division and area — United States, 2011§

Division/Area

All races/ethnicities

No.

Rate

East South Central

98,503

470.7

Alabama

24,768

450.3

Kentucky

24,886

505.5

Mississippi

15,027

464.4

Tennessee

33,822

465.4

West South Central

154,674

423.9

Arkansas

14,742

432.7

Louisiana

23,841

488.1

Oklahoma

18,435

440.6

Texas

97,656

406.7

West

Mountain

Arizona

27,566

383.9

Colorado

21,467

417.0

Idaho

7,449

448.4

Montana

5,633

461.3

Nevada

New Mexico

8,674

373.8

Utah

9,565

416.5

Wyoming

2,676

434.6

Pacific

222,676

428.5

Alaska

2,632

423.1

California

158,647

419.1

Hawaii

6,759

418.9

Oregon

20,336

451.4

Washington

34,302

468.0

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.

§ Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (covering approximately 99% of the U.S. population). Registry-specific data quality information is available at http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_data_quality.htm.

Rates and counts are not presented for the West Census Region, the Mountain Census Division, or Nevada because data from Nevada are not included in this analysis.


TABLE 4. Reported number and rate* of cancer deaths, all cancer sites combined, by geographic division and area — United States, 2011

Division/Area

All races/ethnicities

No.

Rate

United States

576,685

168.7

Northeast

110,262

166.8

New England

29,190

167.4

Connecticut

6,837

157.9

Maine

3,201

181.7

Massachusetts

12,895

166.4

New Hampshire

2,740

178.0

Rhode Island

2,170

168.3

Vermont

1,347

175.6

Middle Atlantic

81,072

166.7

New Jersey

16,708

165.6

New York

35,469

159.6

Pennsylvania

28,895

177.3

Midwest

134,633

176.4

East North Central

94,354

179.3

Illinois

24,006

174.8

Indiana

13,180

185.2

Michigan

20,420

177.4

Ohio

25,140

184.4

Wisconsin

11,608

174.9

West North Central

40,279

170.0

Iowa

6,481

172.4

Kansas

5,440

169.9

Minnesota

9,489

160.5

Missouri

12,473

179.4

Nebraska

3,410

164.2

North Dakota

1,321

160.5

South Dakota

1,665

168.6

South

218,374

173.9

South Atlantic

117,490

168.9

Delaware

1,905

179.7

District of Columbia

1,070

180.6

Florida

41,681

160.2

Georgia

15,602

171.0

Maryland

10,249

165.9

North Carolina

18,284

174.8

South Carolina

9,543

182.2

Virginia

14,374

170.7

West Virginia

4,782

199.6


TABLE 4. (Continued) Reported number and rate* of cancer deaths, all cancer sites combined, by geographic division and area — United States, 2011

Division/Area

All races/ethnicities

No.

Rate

East South Central

39,806

192.6

Alabama

10,233

187.4

Kentucky

9,733

200.9

Mississippi

6,278

196.8

Tennessee

13,562

189.1

West South Central

61,078

172.8

Arkansas

6,497

191.1

Louisiana

9,233

193.5

Oklahoma

7,997

191.2

Texas

37,351

162.6

West

113,416

153.5

Mountain

33,951

149.3

Arizona

10,690

148.4

Colorado

7,051

143.9

Idaho

2,573

157.6

Montana

2,022

164.4

Nevada

4,605

170.3

New Mexico

3,328

146.6

Utah

2,746

125.6

Wyoming

936

156.1

Pacific

79,465

155.4

Alaska

935

176.1

California

56,448

151.8

Hawaii

2,278

138.2

Oregon

7,802

172.2

Washington

12,002

166.6

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Data are from the National Vital Statistics System (NVSS).


TABLE 5. Reported number and rate* of invasive cancer cases, by primary cancer site and age group — United States, 2011§

Cancer site

Age group (yrs)

Total (All ages)

<15

15–24

25–39

40–64

≥65

No.

Rate

No.

Rate

No.

Rate

No.

Rate

No.

Rate

No.

Rate (crude)

All sites combined

10,063

16.6

12,278

28.3

57,032

93.8

630,145

612.1

822,548

2,004.6

1,532,066

496.0

Oral cavity and pharynx

82

0.1

236

0.5

1,202

2.0

21,141

20.5

16,491

40.2

39,152

12.7

Esophagus

138

0.2

6,512

6.3

9,255

22.6

15,914

5.2

Stomach

62

0.1

585

1.0

8,165

7.9

13,603

33.2

7.3

Colon and rectum

25

0

287

0.7

3,302

5.4

51,303

49.8

80,343

195.8

135,260

43.8

Liver and intrahepatic bile duct

211

0.3

57

0.1

298

0.5

13,827

13.4

11,704

28.5

26,097

8.4

Pancreas

45

0.1

398

0.7

13,611

13.2

27,409

66.8

13.4

Larynx

89

0.2

5,935

5.8

6,222

15.2

12,253

4.0

Lung and bronchus

24

0

113

0.3

973

1.6

65,891

64.0

140,336

342.0

207,339

67.1

Melanomas of the skin

129

0.2

939

2.2

5,444

9.0

28,329

27.5

30,806

75.1

65,647

21.3

Female breast

182

0.9

9,457

31.2

114,784

218.4

95,668

411.3

140.2

Cervix

144

0.7

2,761

9.1

6,750

12.8

2,454

10.6

7.7

Corpus and uterus, NOS

43

0.2

1,601

5.3

25,914

49.3

19,977

85.9

30.3

Ovary

101

0.3

303

1.4

986

3.3

9,614

18.3

9,589

41.2

20,593

13.1

Prostate

124

0.4

92,152

182.9

117,001

658.3

209,292

137.8

Testis

56

0.2

1,400

6.3

3,879

12.7

2,412

4.8

194

1.1

7,941

5.2

Urinary bladder

19

0

79

0.2

517

0.9

18,025

17.5

49,430

120.5

68,070

22.0

Kidney and renal pelvis

568

0.9

145

0.3

1,918

3.2

24,850

24.1

25,704

62.6

53,185

17.2

Brain and nervous system

2,112

3.5

1,021

2.4

2,014

3.3

8273

8.0

7,664

18.7

21,084

6.8

Thyroid

197

0.3

1,861

4.3

9,055

14.9

24,165

23.5

9,055

22.1

44,332

14.4

Hodgkin lymphoma

311

0.5

1,556

3.6

2,334

3.8

2,641

2.6

1,574

3.8

8,416

2.7

Non-Hodgkin lymphoma

553

0.9

883

2.0

2,882

4.7

22,951

22.3

35,176

85.7

62,445

20.2

Myeloma

276

0.5

7,622

7.4

12,786

31.2

20,696

6.7

Leukemias

3,094

5.1

1,175

2.7

2,082

3.4

13,190

12.8

23,295

56.8

42,836

13.9

Mesothelioma

35

0.1

713

0.7

2,476

6.0

3,229

1.0

Kaposi Sarcoma

47

0.1

306

0.5

508

0.5

289

0.7

0.4

Abbreviation: NOS = not otherwise specified.

* Rates are the number of cases per 100,000 persons. For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.

§ Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (covering approximately 99% of the U.S. population). Registry-specific data quality information is available at http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_data_quality.htm.

Counts and rates are suppressed if <16 cases were reported in a specific category. Some counts and rates are suppressed as complementary cell suppression.


TABLE 6. Reported number and rate* of cancer deaths, by primary cancer site and age group — United States, 2011

Cancer site

Age group (yrs)

Total (all ages)

<15

15–24

25–39

40–64

≥65

No.

Rate

No.

Rate

No.

Rate

No.

Rate

No.

Rate

No.

Rate (crude)

All sites combined

1,283

2.1

1,611

3.7

7,419

12.1

169,266

163.0

397,106

959.8

576,685

185.1

Oral cavity and pharynx

§

19

0

113

0.2

3,600

3.5

4,919

11.9

2.8

Esophagus

107

0.2

5,392

5.2

8,941

21.6

14,446

4.6

Stomach

16

0

287

0.5

3,402

3.3

7,330

17.7

3.5

Colon and rectum

58

0.1

735

1.2

15,454

14.9

35,534

85.9

16.6

Liver and intrahepatic bile duct

41

0.1

27

0.1

201

0.3

9,375

9.0

11,964

28.9

21,608

6.9

Pancreas

158

0.3

10,621

10.2

26,560

64.2

37,344

12.0

Larynx

1,451

1.4

2,272

5.5

3,732

1.2

Lung and bronchus

30

0.1

379

0.6

44,243

42.6

112,295

271.4

50.4

Melanomas of the skin

25

0.1

310

0.5

3,198

3.1

5,593

13.5

2.9

Female breast

1,033

3.4

16,173

30.5

23,715

101.2

40,931

25.9

Cervix

405

1.3

2,224

4.2

1,450

6.2

4,092

2.6

Corpus and uterus, NOS

75

0.2

2,880

5.4

5,684

24.3

8,641

5.5

Ovary

19

0.1

206

0.7

4,811

9.1

9,306

39.7

9.1

Prostate

2,977

5.9

24,988

139.3

27,970

18.2

Testis

45

0.2

129

0.4

147

0.3

59

0.3

0.2

Urinary bladder

32

0.1

2,404

2.3

12,571

30.4

15,014

4.8

Kidney and renal pelvis

39

0.1

31

0.1

141

0.2

4,279

4.1

9,069

21.9

13,559

4.4

Brain and nervous system

439

0.7

234

0.5

671

1.1

6,126

5.9

7,021

17.0

14,491

4.7

Thyroid

21

0

498

0.5

1,224

3.0

1,747

0.6

Hodgkin lymphoma

56

0.1

158

0.3

332

0.3

621

1.5

0.4

Non-Hodgkin lymphoma

32

0.1

90

0.2

363

0.6

4,470

4.3

15,362

37.1

20,317

6.5

Myeloma

39

0.1

2,569

2.5

8,802

21.3

11,411

3.7

Leukemias

342

0.6

390

0.9

672

1.1

4,738

4.6

17,052

41.2

23,194

7.4

Mesothelioma

460

0.4

2,175

5.3

2,651

0.9

Abbreviation: NOS = not otherwise specified.

* Rates are the number of deaths per 100,000 persons. For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Data are from the National Vital Statistics System (NVSS).

§ Counts and rates are suppressed if <16 cases were reported in a specific category. Some counts and rates are suppressed as complementary cell suppression.


TABLE 7. Reported number and rate* of invasive cancer cases, by primary cancer site and sex — United States, 2011§

Cancer site

Male

Female

Total

No.

Rate

No.

Rate

No.

Rate

All sites combined

786,102

507.5

745,964

410.3

1,532,066

450.6

Oral cavity and pharynx

27,789

17.0

11,363

6.2

39,152

11.2

Lip

1,452

1.0

545

0.3

1,997

0.6

Tongue

8,506

5.1

3,319

1.8

11,825

3.4

Salivary gland

2,411

1.6

1,584

0.9

3,995

1.2

Floor of mouth

1,361

0.8

584

0.3

1,945

0.5

Gum and other mouth

2,933

1.9

2,323

1.2

5,256

1.5

Nasopharynx

1,243

0.8

489

0.3

1,732

0.5

Tonsil

5,914

3.4

1,328

0.7

7,242

2.0

Oropharynx

1,367

0.8

455

0.2

1,822

0.5

Hypopharynx

1,836

1.1

466

0.2

2,302

0.7

Other oral cavity and pharynx

766

0.5

270

0.1

1,036

0.3

Digestive system

148,767

96.5

120,552

64.3

269,319

78.9

Esophagus

12,547

8.0

3,367

1.8

15,914

4.6

Stomach

13,950

9.2

8,474

4.6

22,424

6.6

Small intestine

4,024

2.6

3,662

2.0

7,686

2.2

Colon and rectum

70,099

46.1

65,161

34.9

135,260

39.9

Colon excluding rectum

47,915

32.0

49,055

26.1

96,970

28.7

Rectum and rectosigmoid junction

22,184

14.2

16,106

8.7

38,290

11.2

Anus, anal canal, and anorectum

2,252

1.4

3,815

2.1

6,067

1.8

Liver and intrahepatic bile duct

18,888

11.4

7,209

3.8

26,097

7.3

Gallbladder

1,210

0.8

2,568

1.4

3,778

1.1

Other biliary

3,155

2.1

2,771

1.5

5,926

1.8

Pancreas

21,110

13.8

20,363

10.7

41,473

12.2

Retroperitoneum

613

0.4

645

0.4

1,258

0.4

Peritoneum, omentum, and mesentery

139

0.1

1,784

1.0

1,923

0.6

Other digestive organs

780

0.5

733

0.4

1,513

0.4

Respiratory system

121,781

80.2

100,618

54.0

222,399

65.4

Nose, nasal cavity, and middle ear

1,300

0.8

866

0.5

2,166

0.6

Larynx

9,723

6.1

2,530

1.4

12,253

3.5

Lung and bronchus

110,322

73.0

97,017

52.0

207,339

61.0

Pleura

62

0

36

0

98

0

Trachea, mediastinum, and other respiratory organs

374

0.2

169

0.1

543

0.2

Bones and joints

1,569

1.0

1,320

0.8

2,889

0.9

Soft tissue including heart

5,719

3.8

4,666

2.7

10,385

3.2

Skin excluding basal and squamous

41,573

27.5

29,280

16.8

70,853

21.3

Melanoma of the skin

38,415

25.3

27,232

15.6

65,647

19.7

Other nonepithelial skin

3,158

2.2

2,048

1.1

5,206

1.6

Male and female breast

NA

NA

NA

NA

222,175

65.6

Female breast

NA

NA

220,097

122.0

NA

NA

Male breast

2,078

1.4

NA

NA

NA

NA

Female genital system

NA

NA

88,068

48.4

NA

NA

Cervix

NA

NA

12,109

7.5

NA

NA

Corpus and uterus, NOS

NA

NA

47,537

25.4

NA

NA

Corpus

NA

NA

45,994

24.6

NA

NA

Uterus, NOS

NA

NA

1,543

0.8

NA

NA

Ovary

NA

NA

20,593

11.3

NA

NA

Vagina

NA

NA

1,255

0.7

NA

NA

Vulva

NA

NA

4,596

2.5

NA

NA

Other female genital organs

NA

NA

1,978

1.1

NA

NA


TABLE 7. (Continued) Reported number and rate* of invasive cancer cases, by primary cancer site and sex — United States, 2011§

Cancer site

Male

Female

Total

No.

Rate

No.

Rate

No.

Rate

Male genital system

218,876

134.8

NA

NA

NA

NA

Prostate

209,292

128.3

NA

NA

NA

NA

Testis

7,941

5.3

NA

NA

NA

NA

Penis

1,293

0.9

NA

NA

NA

NA

Other male genital organs

350

0.2

NA

NA

NA

NA

Urinary system

86,200

57.4

37,895

20.4

124,095

36.6

Urinary bladder

51,270

35.1

16,800

8.9

68,070

20.2

Kidney and renal pelvis

33,118

21.0

20,067

11.0

53,185

15.6

Ureter

1,156

0.8

706

0.4

1,862

0.6

Other urinary organs

656

0.5

322

0.2

978

0.3

Eye and orbit

1,357

0.9

1,154

0.7

2,511

0.8

Brain and other nervous system

11,734

7.6

9,350

5.4

21,084

6.4

Brain

11,135

7.2

8,683

5.0

19,818

6.0

Cranial nerves other nervous system

599

0.4

667

0.4

1,266

0.4

Endocrine system

11,969

7.7

34,617

21.2

46,586

14.5

Thyroid

10,789

6.9

33,543

20.5

44,332

13.8

Other endocrine including thymus

1,180

0.8

1,074

0.6

2,254

0.7

Lymphomas

38,780

25.7

32,081

17.8

70,861

21.3

Hodgkin lymphoma

4,694

3.1

3,722

2.3

8,416

2.7

Non-Hodgkin lymphoma

34,086

22.6

28,359

15.5

62,445

18.6

Myeloma

11,388

7.5

9,308

5.0

20,696

6.1

Leukemias

24,528

16.5

18,308

10.2

42,836

13.0

Acute lymphocytic leukemia

2,733

1.8

2,255

1.5

4,988

1.7

Chronic lymphocytic leukemia

8,371

5.6

5,576

2.9

13,947

4.1

Acute myeloid leukemia

7,107

4.8

5,986

3.4

13,093

4.0

Chronic myeloid leukemia

3,092

2.1

2,283

1.3

5,375

1.6

Other leukemia

3,225

2.2

2,208

1.2

5,433

1.6

Mesothelioma

2,414

1.7

815

0.4

3,229

1.0

Kaposi Sarcoma

1,015

0.7

139

0.1

1,154

0.4

Miscellaneous

28,565

19.6

26,333

13.9

54,898

16.3

Abbreviations: NA = not applicable; NOS = not otherwise specified.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.

§ Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (covering approximately 99% of the U.S. population). Registry-specific data quality information is available at http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_data_quality.htm.


TABLE 8. Reported number and rate* of cancer deaths, by primary cancer site and sex —United States, 2011

Cancer site

Male

Female

Total

No.

Rate

No.

Rate

No.

Rate

All sites combined

302,228

204.3

274,457

143.5

576,685

168.7

Oral cavity and pharynx

6,123

3.9

2,534

1.3

8,657

2.5

Lip

60

0

23

0

83

0

Tongue

1,441

0.9

648

0.3

2,089

0.6

Salivary gland

551

0.4

269

0.1

820

0.2

Floor of mouth

59

0

25

0

84

0

Gum and other mouth

712

0.5

533

0.3

1,245

0.4

Nasopharynx

447

0.3

183

0.1

630

0.2

Tonsil

657

0.4

185

0.1

842

0.2

Oropharynx

616

0.4

245

0.1

861

0.2

Hypopharynx

260

0.2

62

0

322

0.1

Other oral cavity and pharynx

1,320

0.8

361

0.2

1,681

0.5

Digestive system

81,563

53.6

62,444

32.2

144,007

41.8

Esophagus

11,514

7.4

2,932

1.5

14,446

4.2

Stomach

6,544

4.4

4,491

2.3

11,035

3.3

Small intestine

681

0.5

575

0.3

1,256

0.4

Colon and rectum

26,804

18.1

24,979

12.8

51,783

15.1

Colon excluding rectum

21,336

14.5

20,845

10.6

42,181

12.3

Rectum and rectosigmoid junction

5,468

3.6

4,134

2.1

9,602

2.8

Anus, anal canal, and anorectum

345

0.2

518

0.3

863

0.2

Liver and intrahepatic bile duct

14,626

9.0

6,982

3.6

21,608

6.1

Gallbladder

705

0.5

1,396

0.7

2,101

0.6

Other biliary

745

0.5

765

0.4

1,510

0.4

Pancreas

18,881

12.5

18,463

9.5

37,344

10.9

Retroperitoneum

113

0.1

106

0.1

219

0.1

Peritoneum, omentum, and mesentery

83

0.1

724

0.4

807

0.2

Other digestive organs

522

0.4

513

0.3

1,035

0.3

Respiratory system

90,099

60.0

71,277

37.6

161,376

47.3

Nose, nasal cavity, and middle ear

249

0.2

167

0.1

416

0.1

Larynx

2,948

1.9

784

0.4

3,732

1.1

Lung and bronchus

86,736

57.9

70,217

37.0

156,953

46.0

Pleura

41

0

20

0

61

0

Trachea, mediastinum, and other respiratory organs

125

0.1

89

0

214

0.1

Bones and joints

814

0.5

609

0.3

1,423

0.4

Soft tissue including heart

2,257

1.5

2,151

1.2

4,408

1.3

Skin excluding basal and squamous

8,241

5.6

3,971

2.1

12,212

3.6

Melanoma of the skin

6,001

4.0

3,127

1.7

9,128

2.7

Other nonepithelial skin

2,240

1.6

844

0.4

3,084

0.9

Male and female breast

NA

NA

40,931

21.5

41,374

12.0

Female breast

NA

NA

NA

NA

NA

NA

Male breast

443

0.3

NA

NA

NA

NA


TABLE 8. (Continued) Reported number and rate* of cancer deaths, by primary cancer site and sex —United States, 2011

Cancer site

Male

Female

Total

No.

Rate

No.

Rate

No.

Rate

Female genital system

NA

NA

29,027

15.3

NA

NA

Cervix

NA

NA

4,092

2.3

NA

NA

Corpus and uterus, NOS

NA

NA

8,641

4.5

NA

NA

Corpus

NA

NA

3,714

1.9

NA

NA

Uterus, NOS

NA

NA

4,927

2.6

NA

NA

Ovary

NA

NA

14,346

7.5

NA

NA

Vagina

NA

NA

428

0.2

NA

NA

Vulva

NA

NA

1,022

0.5

NA

NA

Other female genital organs

NA

NA

498

0.3

NA

NA

Male genital system

28,630

21.2

NA

NA

NA

NA

Prostate

27,970

20.8

NA

NA

NA

NA

Testis

380

0.3

NA

NA

NA

NA

Penis

239

0.2

NA

NA

NA

NA

Other male genital organs

41

0

NA

NA

NA

NA

Urinary system

19,649

13.6

9,668

4.9

29,317

8.6

Urinary bladder

10,594

7.6

4,420

2.2

15,014

4.4

Kidney and renal pelvis

8,632

5.7

4,927

2.5

13,559

3.9

Ureter

180

0.1

158

0.1

338

0.1

Other urinary organs

243

0.2

163

0.1

406

0.1

Eye and orbit

147

0.1

133

0.1

280

0.1

Brain and other nervous system

8,128

5.2

6,363

3.4

14,491

4.3

Endocrine system

1,291

0.8

1,398

0.7

2,689

0.8

Thyroid

788

0.5

959

0.5

1,747

0.5

Other endocrine including thymus

503

0.3

439

0.3

942

0.3

Lymphomas

11,992

8.3

9,493

4.9

21,485

6.4

Hodgkin lymphoma

688

0.5

480

0.3

1,168

0.4

Non-Hodgkin lymphoma

11,304

7.8

9,013

4.6

20,317

6.0

Myeloma

6,165

4.3

5,246

2.7

11,411

3.4

Leukemias

13,219

9.3

9,975

5.2

23,194

6.9

Acute lymphocytic leukemia

773

0.5

659

0.4

1,432

0.4

Chronic lymphocytic leukemia

2,756

2.0

1,852

0.9

4,608

1.4

Acute myeloid leukemia

5,343

3.7

4,148

2.2

9,491

2.8

Chronic myeloid leukemia

597

0.4

494

0.3

1,091

0.3

Other leukemia

3,750

2.7

2,822

1.5

6,572

2.0

Mesothelioma

2,137

1.5

514

0.3

2,651

0.8

Miscellaneous

21,292

14.4

18,710

9.6

40,002

11.7

Abbreviations: NA = not applicable; NOS = not otherwise specified.

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Data are from the National Vital Statistics System (NVSS).


TABLE 9. Reported number and rate* of invasive cancer cases, by primary cancer site and race§ — United States, 2011

Cancer site

AI/AN§

A/PI§

Black

White

Total

No.

Rate

No.

Rate

No.

Rate

No.

Rate

No.

Rate

All sites combined

7,877

273.4

43,738

290.4

165,062

458.3

1,286,265

449.7

1,532,066

450.6

Oral cavity and pharynx

229

7.3

1,171

7.5

3,496

9.1

33,697

11.5

39,152

11.2

Lip

—**

29

0.1

1,884

0.7

1,997

0.6

Tongue

65

1.9

280

1.8

805

2.1

10,522

3.6

11,825

3.4

Salivary gland

24

0.7

140

0.9

376

1.0

3,392

1.2

3,995

1.2

Floor of mouth

16

0.5

22

0.2

218

0.6

1,673

0.6

1,945

0.5

Gum and other mouth

33

1.2

207

1.4

495

1.4

4,407

1.5

5,256

1.5

Nasopharynx

18

0.6

356

2.1

253

0.6

1,076

0.4

1,732

0.5

Tonsil

34

1.1

72

0.4

600

1.5

6,461

2.2

7,242

2.0

Oropharynx

25

0.2

257

0.7

1,519

0.5

1,822

0.5

Hypopharynx

18

0.6

48

0.3

350

0.9

1,868

0.6

2,302

0.7

Other oral cavity and pharynx

113

0.3

895

0.3

1,036

0.3

Digestive system

1,718

61.2

10,626

73.4

34,031

96.8

219,964

76.1

269,319

78.9

Esophagus

78

2.8

301

2.1

1,600

4.4

13,787

4.7

15,914

4.6

Stomach

146

5.4

1,469

10.3

3,518

10.5

16,998

5.9

22,424

6.6

Small intestine

34

1.3

153

1.0

1,260

3.6

6,154

2.1

7,686

2.2

Colon and rectum

821

29.1

4,730

32.4

16,348

46.7

111,649

38.9

135,260

39.9

Colon excluding rectum

550

20.3

3,018

21.1

12,234

35.5

80,037

27.9

96,970

28.7

Rectum and rectosigmoid junction

271

8.8

1,712

11.2

4,114

11.2

31,612

11.0

38,290

11.2

Anus, anal canal, and anorectum

35

1.1

81

0.5

682

1.8

5,201

1.8

6,067

1.8

Liver and intrahepatic bile duct

288

9.5

1,952

13.0

3,910

9.8

19,655

6.6

26,097

7.3

Gallbladder

38

1.6

179

1.3

573

1.7

2,959

1.0

3,778

1.1

Other biliary

34

1.4

342

2.4

553

1.7

4,953

1.7

5,926

1.8

Pancreas

211

7.9

1,238

9.1

5,127

15.2

34,620

11.9

41,473

12.2

Retroperitoneum

53

0.3

131

0.3

1,052

0.4

1,258

0.4

Peritoneum, omentum, and mesentery

55

0.4

146

0.4

1,705

0.6

1,923

0.6

Other digestive organs

73

0.5

183

0.6

1,231

0.4

1,513

0.4

Respiratory system

1,156

45.5

5,051

36.6

23,882

69.2

191,119

66.0

222,399

65.4

Nose, nasal cavity and middle ear

27

0.9

72

0.5

204

0.6

1,833

0.6

2,166

0.6

Larynx

58

1.9

183

1.3

1,699

4.5

10,192

3.5

12,253

3.5

Lung and bronchus

1,065

42.5

4,770

34.7

21,905

64.0

178,564

61.7

207,339

61.0

Pleura

83

0

98

0

Trachea, mediastinum, and other
respiratory organs

24

0.1

61

0.2

447

0.2

543

0.2

Bones and joints

29

0.8

102

0.6

285

0.7

2,425

1.0

2,889

0.9

Soft tissue including heart

50

1.5

383

2.4

1,254

3.3

8,549

3.1

10,385

3.2

Skin excluding basal and squamous

143

4.9

290

1.9

660

1.8

65,892

23.7

70,853

21.3

Melanomas of the skin

128

4.3

197

1.3

359

1.0

61,337

22.1

65,647

19.7

Other nonepithelial skin

93

0.6

301

0.8

4,555

1.6

5,206

1.6

Male and female breast

1,155

37.4

7,861

48.2

25,465

69.2

185,360

65.4

222,175

65.6

Female breast

1,146

69.6

7,826

87.8

25,198

121.2

183,621

122.8

220,097

122.0

Male breast

35

0.5

267

1.9

1,739

1.3

2,078

1.4


TABLE 9. (Continued) Reported number and rate* of invasive cancer cases, by primary cancer site and race§ — United States, 2011

Cancer site

AI/AN§

A/PI§

Black

White

Total

No.

Rate

No.

Rate

No.

Rate

No.

Rate

No.

Rate

Female genital system

549

31.7

3,072

34.0

9,522

46.0

73,799

49.2

88,068

48.4

Cervix

116

6.3

534

5.9

1,882

9.0

9,350

7.3

12,109

7.5

Corpus and uterus, NOS

260

14.7

1,584

17.3

5,123

24.6

39,960

25.7

47,537

25.4

Corpus

247

14.0

1,532

16.7

4,775

22.9

38,846

25.0

45,994

24.6

Uterus, NOS

52

0.6

348

1.7

1,114

0.7

1,543

0.8

Ovary

132

7.9

789

8.9

1,796

8.8

17,701

11.7

20,593

11.3

Vagina

31

0.4

190

0.9

997

0.6

1,255

0.7

Vulva

22

1.4

63

0.8

343

1.7

4,095

2.7

4,596

2.5

Other female genital organs

71

0.8

188

0.9

1,696

1.1

1,978

1.1

Male genital system

843

65.8

4,516

69.6

31,328

197.3

172,005

124.5

218,876

134.8

Prostate

770

62.2

4,302

67.1

30,864

194.7

163,395

117.2

209,292

128.3

Testis

65

2.8

175

1.9

286

1.5

7,230

6.2

7,941

5.3

Penis

26

0.4

141

0.9

1,095

0.9

1,293

0.9

Other male genital organs

37

0.2

285

0.2

350

0.2

Urinary system

671

23.8

2,322

16.3

10,180

29.1

109,214

38.0

124,095

36.6

Urinary bladder

201

8.4

1,086

8.1

3,697

11.4

61,930

21.4

68,070

20.2

Kidney and renal pelvis

461

15.0

1,137

7.4

6,291

17.1

44,786

15.7

53,185

15.6

Ureter

73

0.6

80

0.3

1,693

0.6

1,862

0.6

Other urinary organs

26

0.2

112

0.3

805

0.3

978

0.3

Eye and orbit

48

0.3

92

0.2

2,294

0.8

2,511

0.8

Brain and other nervous system

110

3.1

550

3.4

1,549

4.0

18,625

6.9

21,084

6.4

Brain

99

2.8

515

3.2

1,427

3.7

17,557

6.5

19,818

6.0

Cranial nerves other nervous system

35

0.2

122

0.3

1,068

0.4

1,266

0.4

Endocrine system

229

6.2

2,547

14.8

3,822

9.7

39,097

15.1

46,586

14.5

Thyroid

220

6.0

2,426

14.0

3,453

8.8

37,370

14.4

44,332

13.8

Other endocrine including thymus

121

0.7

369

0.9

1,727

0.7

2,254

0.7

Lymphomas

335

11.4

2,120

14.1

5,998

16.1

61,044

21.9

70,861

21.3

Hodgkin lymphoma

40

1.0

201

1.2

1,128

2.7

6,913

2.8

8,416

2.7

Non-Hodgkin lymphoma

295

10.3

1,919

13.0

4,870

13.4

54,131

19.1

62,445

18.6

Myeloma

92

3.4

500

3.5

4,072

11.8

15,688

5.4

20,696

6.1

Leukemias

224

6.8

1,151

7.6

3,590

10.0

36,718

13.3

42,836

13.0

Acute lymphocytic leukemia

40

0.8

224

1.4

446

1.0

4,147

1.8

4,988

1.7

Chronic lymphocytic leukemia

39

1.5

170

1.2

930

2.8

12,168

4.2

13,947

4.1

Acute myeloid leukemia

76

2.2

489

3.3

1,163

3.3

11,231

4.1

13,093

4.0

Chronic myeloid leukemia

40

1.2

144

0.9

546

1.5

4,513

1.6

5,375

1.6

Other leukemia

29

1.0

124

0.8

505

1.5

4,659

1.7

5,433

1.6

Mesothelioma

50

0.4

149

0.5

3,008

1.1

3,229

1.0

Kaposi Sarcoma

16

0.1

355

0.9

717

0.3

1,154

0.4

Miscellaneous

318

12.8

1,362

10.1

5,332

16.1

47,050

16.3

54,898

16.3

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander; NOS = not otherwise specified.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.

§ Rates are not presented for persons of unknown or other race, therefore categories do not sum to total. Data for specified racial populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes/interpreting/race.htm).

Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (covering approximately 99% of the U.S. population). Registry-specific data quality information is available at http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_data_quality.htm.

** Counts and rates are suppressed if <16 cases were reported.


TABLE 10. Reported number and rate* of cancer deaths, by primary cancer site and race — United States, 2011§

Cancer site

AI/AN

A/PI

Black

White

Total

No.

Rate

No.

Rate

No.

Rate

No.

Rate

No.

Rate

All sites combined

2,810

111.5

14,713

105.5

66,817

199.2

492,345

168.5

576,685

168.7

Oral cavity and pharynx

58

2.1

286

1.9

1,126

3.1

7,187

2.4

8,657

2.5

Lip

77

0

83

0

Tongue

16

0.5

52

0.4

215

0.6

1,806

0.6

2,089

0.6

Salivary gland

21

0.1

73

0.2

726

0.2

820

0.2

Floor of mouth

72

0

84

0

Gum and other mouth

30

0.2

119

0.3

1,087

0.4

1,245

0.4

Nasopharynx

129

0.8

85

0.2

409

0.1

630

0.2

Tonsil

96

0.3

736

0.2

842

0.2

Oropharynx

165

0.4

673

0.2

861

0.2

Hypopharynx

61

0.2

252

0.1

322

0.1

Other oral cavity and pharynx

22

0.2

297

0.8

1,349

0.5

1,681

0.5

Digestive system

851

32.8

5,296

38.0

18,712

55.3

119,148

40.5

144,007

41.8

Esophagus

54

1.9

235

1.6

1,352

3.8

12,805

4.3

14,446

4.2

Stomach

76

3.1

775

5.6

1,979

6.1

8,205

2.8

11,035

3.3

Small intestine

30

0.2

207

0.6

1,015

0.4

1,256

0.4

Colon and rectum

318

12.3

1,492

10.7

7,017

21.1

42,956

14.6

51,783

15.1

Colon excluding rectum

238

9.3

1,184

8.7

5,925

17.9

34,834

11.9

42,181

12.3

Rectum and rectosigmoid junction

80

3.0

308

2.1

1,092

3.2

8,122

2.8

9,602

2.8

Anus, anal canal, and anorectum

102

0.3

740

0.3

863

0.2

Liver and intrahepatic bile duct

180

6.5

1,436

9.9

3,041

8.1

16,951

5.7

21,608

6.1

Gallbladder

23

1.0

102

0.8

306

0.9

1,670

0.6

2,101

0.6

Other biliary

71

0.5

121

0.4

1,306

0.4

1,510

0.4

Pancreas

162

6.5

1,083

8.0

4,380

13.3

31,719

10.8

37,344

10.9

Retroperitoneum

16

0

196

0.1

219

0.1

Peritoneum, omentum, and mesentery

19

0.1

46

0.1

738

0.3

807

0.2

Other digestive organs

33

0.2

145

0.4

847

0.3

1,035

0.3

Respiratory system

765

31.2

3,409

25.2

17,322

51.4

139,880

47.9

161,376

47.3

Nose, nasal cavity, and middle ear

18

0.1

58

0.2

338

0.1

416

0.1

Larynx

18

0.6

54

0.4

655

1.8

3,005

1.0

3,732

1.1

Lung and bronchus

743

30.5

3,331

24.7

16,586

49.3

136,293

46.7

156,953

46.0

Pleura

55

0

61

0

Trachea, mediastinum, and other
respiratory organs

19

0.1

189

0.1

214

0.1

Bones and joints

36

0.2

168

0.5

1,211

0.4

1,423

0.4

Soft tissue including heart

157

1.0

542

1.4

3,694

1.3

4,408

1.3

Skin excluding basal and squamous

35

1.3

74

0.5

286

0.8

11,817

4.1

12,212

3.6

Melanomas of the skin

21

0.8

46

0.3

133

0.4

8,928

3.1

9,128

2.7

Other nonepithelial skin

28

0.2

153

0.4

2,889

1.0

3,084

0.9

Male and female breast

165

6.1

985

6.3

6,261

17.7

33,963

11.6

41,374

12.0

Female breast

164

11.0

977

11.2

6,192

30.2

33,598

20.9

40,931

21.5

Male breast

69

0.5

365

0.3

443

0.3


TABLE 10. (Continued) Reported number and rate* of cancer deaths, by primary cancer site and race — United States, 2011§

Cancer site

AI/AN

A/PI

Black

White

Total

No.

Rate

No.

Rate

No.

Rate

No.

Rate

No.

Rate

Female genital system

144

9.3

830

9.6

3,870

19.5

24,183

15.2

29,027

15.3

Cervix

30

1.7

173

2.0

815

4.0

3,074

2.1

4,092

2.3

Corpus and uterus, NOS

41

2.8

248

2.8

1,577

8.0

6,775

4.1

8,641

4.5

Corpus

116

1.3

611

3.1

2,972

1.8

3,714

1.9

Uterus, NOS

26

1.6

132

1.5

966

4.9

3,803

2.3

4,927

2.6

Ovary

65

4.4

389

4.5

1,293

6.6

12,599

7.8

14,346

7.5

Vagina

54

0.3

368

0.2

428

0.2

Vulva

79

0.4

936

0.6

1,022

0.5

Other female genital organs

52

0.3

431

0.3

498

0.3

Male genital system

130

16.7

465

9.6

4,711

44.5

23,324

19.7

28,630

21.2

Prostate

129

16.7

455

9.5

4,658

44.1

22,728

19.2

27,970

20.8

Testis

20

0.1

355

0.3

380

0.3

Penis

26

0.2

207

0.2

239

0.2

Other male genital organs

34

0

41

0

Urinary system

154

6.3

480

3.6

2,446

7.6

26,237

8.9

29,317

8.6

Urinary bladder

47

2.2

195

1.6

1,110

3.6

13,662

4.6

15,014

4.4

Kidney and renal pelvis

107

4.2

267

1.9

1,281

3.8

11,904

4.0

13,559

3.9

Ureter

314

0.1

338

0.1

Other urinary organs

40

0.1

357

0.1

406

0.1

Eye and orbit

263

0.1

280

0.1

Brain and other nervous system

62

1.9

291

1.8

887

2.4

13,251

4.6

14,491

4.3

Endocrine system

133

0.9

276

0.8

2,267

0.8

2,689

0.8

Thyroid

98

0.7

146

0.4

1,494

0.5

1,747

0.5

Other endocrine including thymus

35

0.2

130

0.3

773

0.3

942

0.3

Lymphomas

72

2.9

552

4.2

1,596

4.7

19,265

6.7

21,485

6.4

Hodgkin lymphoma

21

0.2

129

0.3

1,016

0.4

1,168

0.4

Non-Hodgkin lymphoma

70

2.8

531

4.0

1,467

4.4

18,249

6.3

20,317

6.0

Myeloma

44

1.8

236

1.8

1,945

6.1

9,186

3.2

11,411

3.4

Leukemias

78

3.0

585

4.1

1,977

6.0

20,554

7.2

23,194

6.9

Acute lymphocytic leukemia

61

0.4

124

0.3

1,237

0.5

1,432

0.4

Chronic lymphocytic leukemia

36

0.3

380

1.2

4,180

1.4

4,608

1.4

Acute myeloid leukemia

34

1.3

311

2.1

742

2.2

8,404

3.0

9,491

2.8

Chronic myeloid leukemia

29

0.2

128

0.4

932

0.3

1,091

0.3

Other leukemia

20

0.7

148

1.1

603

1.9

5,801

2.0

6,572

2.0

Mesothelioma

30

0.2

109

0.3

2,504

0.9

2,651

0.8

Miscellaneous

206

8.5

861

6.3

4,565

13.7

34,370

11.7

40,002

11.7

Abbreviations: AI/AN = American Indian/Alaska Native; A/PI = Asian/Pacific Islander; NOS = not otherwise specified.

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Data for specified racial populations other than white and black should be interpreted with caution. For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes/interpreting/race.htm).

§ Data are from the National Vital Statistics System (NVSS).

Counts and rates are suppressed if <16 cases were reported.


TABLE 11. Reported number and rate* of invasive cancer cases, by primary cancer site and ethnicity§ — United States, 2011

Cancer site

Hispanic

Non-Hispanic

Total

No.

Rate

No.

Rate

No.

Rate

All sites combined

109,279

350.6

1,422,787

461.5

1,532,066

450.6

Oral cavity and pharynx

2,327

7.3

36,825

11.7

39,152

11.2

Lip

92

0.3

1,905

0.6

1,997

0.6

Tongue

624

2.0

11,201

3.5

11,825

3.4

Salivary gland

291

0.9

3,704

1.2

3,995

1.2

Floor of mouth

113

0.4

1,832

0.6

1,945

0.5

Gum and other mouth

349

1.1

4,907

1.6

5,256

1.5

Nasopharynx

122

0.3

1,610

0.5

1,732

0.5

Tonsil

400

1.2

6,842

2.1

7,242

2.0

Oropharynx

102

0.3

1,720

0.5

1,822

0.5

Hypopharynx

155

0.5

2,147

0.7

2,302

0.7

Other oral cavity and pharynx

79

0.3

957

0.3

1,036

0.3

Digestive system

23,390

80.4

245,929

78.9

269,319

78.9

Esophagus

783

2.8

15,131

4.8

15,914

4.6

Stomach

2,880

9.8

19,544

6.3

22,424

6.6

Small intestine

501

1.7

7,185

2.3

7,686

2.2

Colon and rectum

10,342

35.4

124,918

40.5

135,260

39.9

Colon excluding rectum

7,077

24.9

89,893

29.1

96,970

28.7

Rectum and rectosigmoid junction

3,265

10.5

35,025

11.3

38,290

11.2

Anus, anal canal, and anorectum

430

1.4

5,637

1.8

6,067

1.8

Liver and intrahepatic bile duct

3,855

12.6

22,242

6.9

26,097

7.3

Gallbladder

525

2.0

3,253

1.0

3,778

1.1

Other biliary

639

2.4

5,287

1.7

5,926

1.8

Pancreas

3,001

11.1

38,472

12.3

41,473

12.2

Retroperitoneum

139

0.4

1,119

0.4

1,258

0.4

Peritoneum, omentum, and mesentery

135

0.5

1,788

0.6

1,923

0.6

Other digestive organs

160

0.6

1,353

0.4

1,513

0.4

Respiratory system

9,551

35.5

212,848

68.1

222,399

65.4

Nose, nasal cavity, and middle ear

191

0.6

1,975

0.7

2,166

0.6

Larynx

733

2.5

11,520

3.6

12,253

3.5

Lung and bronchus

8,539

32.2

198,800

63.7

207,339

61.0

Pleura

—**

92

0

0

Trachea, mediastinum, and other respiratory organs

82

0.2

461

0.2

543

0.2

Bones and joints

405

0.9

2,484

0.9

2,889

0.9

Soft tissue including heart

1,050

2.8

9,335

3.2

10,385

3.2

Skin excluding basal and squamous

1,666

5.1

69,187

23.2

70,853

21.3

Melanomas of the skin

1,371

4.1

64,276

21.6

65,647

19.7

Other nonepithelial skin

295

0.9

4,911

1.6

5,206

1.6

Male and female breast

16,555

49.5

205,620

67.5

222,175

65.6

Female breast

16,441

92.1

203,656

125.4

220,097

122.0

Male breast

114

0.8

1,964

1.4

2,078

1.4


TABLE 11. (Continued) Reported number and rate* of invasive cancer cases, by primary cancer site and ethnicity§ — United States, 2011

Cancer site

Hispanic

Non-Hispanic

Total

No.

Rate

No.

Rate

No.

Rate

Female genital system

8,251

44.9

79,817

48.7

88,068

48.4

Cervix

1,998

9.8

10,111

7.2

12,109

7.5

Corpus and uterus, NOS

3,923

21.8

43,614

25.7

47,537

25.4

Corpus

3,744

20.8

42,250

24.9

45,994

24.6

Uterus, NOS

179

1.0

1,364

0.8

1,543

0.8

Ovary

1,812

10.1

18,781

11.5

20,593

11.3

Vagina

104

0.6

1,151

0.7

1,255

0.7

Vulva

268

1.7

4,328

2.6

4,596

2.5

Other female genital organs

146

0.8

1,832

1.1

1,978

1.1

Male genital system

14,744

110.2

204,132

137.4

218,876

134.8

Prostate

13,303

104.4

195,989

130.8

209,292

128.3

Testis

1,227

4.3

6,714

5.6

7,941

5.3

Penis

184

1.3

1,109

0.8

1,293

0.9

Other male genital organs

30

0.2

320

0.2

350

0.2

Urinary system

7,923

27.0

116,172

37.5

124,095

36.6

Urinary bladder

2,847

11.0

65,223

21.0

68,070

20.2

Kidney and renal pelvis

4,954

15.5

48,231

15.7

53,185

15.6

Ureter

65

0.3

1,797

0.6

1,862

0.6

Other urinary organs

57

0.2

921

0.3

978

0.3

Eye and orbit

206

0.5

2,305

0.8

2,511

0.8

Brain and other nervous system

1,998

5.0

19,086

6.7

21,084

6.4

Brain

1,860

4.7

17,958

6.2

19,818

6.0

Cranial nerves other nervous system

138

0.3

1,128

0.4

1,266

0.4

Endocrine system

5,194

12.8

41,392

14.9

46,586

14.5

Thyroid

4,937

12.2

39,395

14.2

44,332

13.8

Other endocrine including thymus

257

0.6

1,997

0.7

2,254

0.7

Lymphomas

6,249

19.1

64,612

21.7

70,861

21.3

Hodgkin lymphoma

1,025

2.3

7,391

2.8

8,416

2.7

Non-Hodgkin lymphoma

5,224

16.7

57,221

18.8

62,445

18.6

Myeloma

1,712

6.0

18,984

6.1

20,696

6.1

Leukemias

3,843

10.3

38,993

13.1

42,836

13.0

Acute lymphocytic leukemia

1,263

2.3

3,725

1.5

4,988

1.7

Chronic lymphocytic leukemia

494

1.8

13,453

4.3

13,947

4.1

Acute myeloid leukemia

1,157

3.4

11,936

4.0

13,093

4.0

Chronic myeloid leukemia

516

1.5

4,859

1.6

5,375

1.6

Other leukemia

413

1.2

5,020

1.7

5,433

1.6

Mesothelioma

193

0.7

3,036

1.0

3,229

1.0

Kaposi Sarcoma

219

0.6

935

0.4

1,154

0.4

Miscellaneous

3,803

14.1

51,095

16.5

54,898

16.3

Abbreviation: NOS = not otherwise specified.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.

§ Data for specified ethnic populations should be interpreted with caution. For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes/interpreting/race.htm).

Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined (covering approximately 99% of the U.S. population). Registry-specific data quality information is available at http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_data_quality.htm.

** Counts and rates are suppressed if <16 cases were reported. Some counts and rates are suppressed as complementary cell suppression.


TABLE 12. Reported number and rate* of cancer deaths, by primary cancer site and ethnicity — United States, 2011§

Cancer site

Hispanic

Non-Hispanic

Total

No.

Rate

No.

Rate

No.

Rate

All sites combined

32,380

117.9

543,371

173.0

576,685

168.7

Oral cavity and pharynx

418

1.5

8,219

2.6

8,657

2.5

Lip

80

0

83

0

Tongue

96

0.3

1,989

0.6

2,089

0.6

Salivary gland

37

0.1

781

0.2

820

0.2

Floor of mouth

81

0

84

0

Gum and other mouth

46

0.2

1,197

0.4

1,245

0.4

Nasopharynx

46

0.1

581

0.2

630

0.2

Tonsil

37

0.1

804

0.2

842

0.2

Oropharynx

45

0.2

813

0.3

861

0.2

Hypopharynx

306

0.1

322

0.1

Other oral cavity and pharynx

90

0.3

1,587

0.5

1,681

0.5

Digestive system

10,929

39.8

132,820

41.9

144,007

41.8

Esophagus

673

2.5

13,749

4.3

14,446

4.2

Stomach

1,500

5.2

9,509

3.0

11,035

3.3

Small intestine

69

0.2

1,184

0.4

1,256

0.4

Colon and rectum

3,235

11.9

48,464

15.4

51,783

15.1

Colon excluding rectum

2,654

10.0

39,463

12.5

42,181

12.3

Rectum and rectosigmoid junction

581

2.0

9,001

2.9

9,602

2.8

Anus, anal canal, and anorectum

39

0.1

823

0.3

863

0.2

Liver and intrahepatic bile duct

2,568

9.0

18,995

5.9

21,608

6.1

Gallbladder

274

1.0

1,820

0.6

2,101

0.6

Other biliary

130

0.5

1,379

0.4

1,510

0.4

Pancreas

2,305

8.8

34,975

11.1

37,344

10.9

Retroperitoneum

204

0.1

219

0.1

Peritoneum, omentum, and mesentery

45

0.2

762

0.2

807

0.2

Other digestive organs

76

0.3

956

0.3

1,035

0.3

Respiratory system

5,367

20.9

155,762

49.5

161,376

47.3

Nose, nasal cavity, and middle ear

29

0.1

385

0.1

416

0.1

Larynx

230

0.9

3,491

1.1

3,732

1.1

Lung and bronchus

5,088

19.9

151,631

48.2

156,953

46.0

Pleura

58

0

0

Trachea, mediastinum, and other respiratory organs

17

0

197

0.1

214

0.1

Bones and joints

151

0.4

1,269

0.4

1,423

0.4

Soft tissue including heart

340

1.0

4,060

1.3

4,408

1.3

Skin excluding basal and squamous

328

1.2

11,870

3.8

12,212

3.6

Melanomas of the skin

235

0.8

8,884

2.9

9,128

2.7

Other nonepithelial skin

93

0.4

2,986

0.9

3,084

0.9

Male and female breast

2,388

7.9

38,916

12.4

41,374

12.0

Female breast

2,369

14.1

38,494

22.2

40,931

21.5

Male breast

19

0.2

422

0.3

443

0.3


TABLE 12. (Continued) Reported number and rate* of cancer deaths, by primary cancer site and ethnicity — United States, 2011§

Cancer site

Hispanic

Non-Hispanic

Total

No.

Rate

No.

Rate

No.

Rate

Female genital system

2,018

12.3

26,962

15.6

29,027

15.3

Cervix

471

2.6

3,613

2.3

4,092

2.3

Corpus and uterus, NOS

582

3.6

8,046

4.5

8,641

4.5

Corpus

215

1.3

3,492

2.0

3,714

1.9

Uterus, NOS

367

2.3

4,554

2.6

4,927

2.6

Ovary

852

5.3

13,471

7.7

14,346

7.5

Vagina

29

0.2

399

0.2

428

0.2

Vulva

55

0.4

965

0.5

1,022

0.5

Other female genital organs

29

0.2

468

0.3

498

0.3

Male genital system

1,701

18.0

26,876

21.4

28,630

21.2

Prostate

1,576

17.4

26,343

21.0

27,970

20.8

Testis

83

0.3

296

0.2

380

0.3

Penis

40

0.3

198

0.1

239

0.2

Other male genital organs

39

0

41

0

Urinary system

1,556

5.9

27,721

8.8

29,317

8.6

Urinary bladder

558

2.4

14,437

4.6

15,014

4.4

Kidney and renal pelvis

974

3.5

12,565

4.0

13,559

3.9

Ureter

332

0.1

338

0.1

Other urinary organs

19

0.1

387

0.1

406

0.1

Eye and orbit

17

0

262

0.1

280

0.1

Brain and other nervous system

918

2.7

13,554

4.4

14,491

4.3

Endocrine system

237

0.8

2,447

0.8

2,689

0.8

Thyroid

160

0.6

1,584

0.5

1,747

0.5

Other endocrine including thymus

77

0.2

863

0.3

942

0.3

Lymphomas

1,481

5.5

19,971

6.5

21,485

6.4

Hodgkin lymphoma

140

0.4

1,022

0.4

1,168

0.4

Non-Hodgkin lymphoma

1,341

5.0

18,949

6.1

20,317

6.0

Myeloma

742

2.9

10,655

3.4

11,411

3.4

Leukemias

1,492

4.7

21,676

7.1

23,194

6.9

Acute lymphocytic leukemia

315

0.7

1,115

0.4

1,432

0.4

Chronic lymphocytic leukemia

106

0.5

4,500

1.4

4,608

1.4

Acute myeloid leukemia

552

1.8

8,927

2.9

9,491

2.8

Chronic myeloid leukemia

96

0.3

994

0.3

1,091

0.3

Other leukemia

423

1.5

6,140

2.0

6,572

2.0

Mesothelioma

100

0.4

2,545

0.8

2,651

0.8

Miscellaneous

2,191

8.2

37,742

12.0

40,002

11.7

Abbreviation: NOS = not otherwise specified.

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

§ Data for specified ethnic populations should be interpreted with caution. For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes/interpreting/race.htm).

Data are from the National Vital Statistics System (NVSS).

Counts and rates are suppressed if <16 cases were reported. Some counts and rates are suppressed as complementary cell suppression.


TABLE 13. Reported rate* of invasive cancer cases, by primary cancer site and year — United States, 1999–2011§

Cancer site

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

All sites combined

484.6

485.8

488.1

483.9

473

471.9

471.1

473.4

475.7

470.3

464.2

449.6

444.2

Oral cavity and pharynx

10.9

10.8

10.8

10.8

10.8

10.8

10.6

10.7

11.0

11.2

11.1

11.1

11.2

Lip

1.0

0.9

0.9

0.9

0.7

0.7

0.7

0.6

0.6

0.6

0.6

0.6

0.6

Tongue

2.6

2.7

2.7

2.8

2.8

2.9

2.9

3.0

3.1

3.3

3.3

3.2

3.4

Salivary gland

1.2

1.2

1.2

1.2

1.2

1.2

1.2

1.3

1.2

1.3

1.3

1.2

1.2

Floor of mouth

0.8

0.8

0.8

0.8

0.7

0.7

0.6

0.7

0.6

0.6

0.6

0.6

0.5

Gum and other mouth

1.7

1.6

1.6

1.6

1.6

1.6

1.5

1.5

1.6

1.6

1.5

1.5

1.5

Nasopharynx

0.6

0.6

0.5

0.6

0.6

0.6

0.6

0.5

0.6

0.6

0.5

0.5

0.5

Tonsil

1.3

1.4

1.4

1.5

1.6

1.6

1.6

1.7

1.8

1.8

2.0

1.9

2.0

Oropharynx

0.4

0.4

0.4

0.4

0.5

0.5

0.4

0.5

0.5

0.5

0.5

0.5

0.5

Hypopharynx

0.9

0.8

0.8

0.8

0.8

0.8

0.7

0.7

0.7

0.7

0.7

0.6

0.6

Other oral cavity and pharynx

0.4

0.4

0.4

0.3

0.3

0.3

0.3

0.2

0.3

0.3

0.2

0.3

0.3

Digestive system

92.0

91.8

91.4

90.3

89.8

88.8

87.4

86.4

85.5

84.7

82.8

80.3

79.1

Esophagus

5.0

5.0

5.0

4.9

5.0

5.1

5.0

5.1

4.9

5.0

4.9

4.6

4.6

Stomach

7.7

7.5

7.4

7.4

7.3

7.2

7.0

6.9

6.9

6.7

6.7

6.8

6.7

Small intestine

1.7

1.7

1.8

1.8

1.9

1.9

2.0

2.1

2.1

2.2

2.2

2.3

2.2

Colon and rectum

56.5

56.1

55.2

53.9

52.6

51.0

49.6

48.1

46.8

45.5

43.3

41.0

39.9

Colon excluding rectum

41.2

40.9

40.4

39.5

38.5

37.2

36.0

35.0

34.0

33.0

31.2

29.5

28.7

Rectum and rectosigmoid junction

15.3

15.1

14.8

14.4

14.1

13.8

13.6

13.1

12.9

12.5

12.1

11.5

11.3

Anus, anal canal, and anorectum

1.4

1.4

1.4

1.4

1.5

1.6

1.6

1.6

1.7

1.7

1.8

1.7

1.8

Liver and intrahepatic bile duct

4.9

5.2

5.2

5.4

5.6

6.0

6.2

6.4

6.8

7.0

7.4

7.4

7.4

Gallbladder

1.2

1.2

1.2

1.1

1.2

1.2

1.2

1.2

1.1

1.1

1.2

1.2

1.1

Other biliary

1.3

1.4

1.6

1.7

1.7

1.7

1.7

1.7

1.7

1.8

1.8

1.7

1.8

Pancreas

11.1

11.2

11.3

11.3

11.5

11.6

11.8

12.0

12.0

12.2

12.1

12.2

12.1

Retroperitoneum

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

Peritoneum, omentum, and mesentery

0.4

0.5

0.5

0.6

0.6

0.7

0.6

0.6

0.6

0.7

0.6

0.6

0.6

Other digestive organs

0.3

0.3

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

Respiratory system

76.2

75.5

75.3

74.9

74.6

73.7

73.9

72.9

71.9

71

69.7

67

64.7

Nose, nasal cavity, and middle ear

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.6

0.6

Larynx

4.6

4.5

4.4

4.1

4.1

4.1

4.0

3.9

3.8

3.7

3.7

3.6

3.4

Lung and bronchus

70.7

70.1

70.1

69.8

69.6

68.7

69.0

68.1

67.1

66.3

65.1

62.5

60.4

Pleura

0

0

0

0

0

0

0

0

0

0

0

0

0

Trachea, mediastinum, and other respiratory organs

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

Bones and joints

1.0

0.9

1.0

1.0

1.0

1.0

1.0

1.0

1.0

0.9

1.0

0.9

0.9

Soft tissue including heart

2.9

3.0

3.0

3.0

3.1

3.2

3.3

3.2

3.3

3.3

3.3

3.3

3.2

Skin excluding basal and squamous

16.6

17.7

18.7

19.1

18.9

19.8

21

20.7

21.1

21.5

21.8

21.2

21.4

Melanomas of the skin

15.3

16.3

17.2

17.6

17.4

18.3

19.4

19.1

19.4

19.8

20.1

19.6

19.8

Other nonepithelial skin

1.3

1.4

1.5

1.5

1.5

1.5

1.6

1.6

1.6

1.7

1.7

1.6

1.6

Male and female breast

74.3

72.8

72.4

70.5

66.8

66.0

65.7

66.0

66.5

66.9

67.4

64.9

65.7

Female breast

135.3

133.0

132.6

129.3

122.7

121.5

121.1

121.8

123.0

123.9

124.9

120.5

122.3

Male breast

1.3

1.3

1.2

1.3

1.3

1.3

1.3

1.3

1.3

1.4

1.4

1.4

1.4


TABLE 13. (Continued) Reported rate* of invasive cancer cases, by primary cancer site and year — United States, 1999–2011§

Cancer site

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

Female genital system

52.1

51.8

51.7

50.5

49.1

49.1

49.3

49.2

49.4

49.6

49.8

49

48.9

Cervix

9.7

9.6

9.1

8.7

8.4

8.2

8.3

8.2

8.1

7.9

8.0

7.6

7.5

Corpus and uterus, NOS

24.3

24.1

24.6

24.2

23.3

23.9

24.2

24.3

24.6

25.0

25.5

25.4

25.6

Corpus

23.5

23.3

23.8

23.5

22.6

23.2

23.4

23.6

23.9

24.2

24.7

24.7

24.8

Uterus, NOS

0.8

0.8

0.8

0.8

0.7

0.7

0.7

0.7

0.7

0.8

0.8

0.8

0.8

Ovary

14.4

14.4

14.3

13.8

13.7

13.2

13.2

13.0

12.7

12.6

12.2

11.7

11.4

Vagina

0.7

0.7

0.7

0.7

0.7

0.7

0.6

0.7

0.7

0.7

0.7

0.7

0.7

Vulva

2.4

2.3

2.4

2.3

2.4

2.3

2.4

2.4

2.5

2.5

2.5

2.5

2.5

Other female genital organs

0.6

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.8

0.9

0.9

1

1.1

Male genital system

176.7

178.5

180.6

178.2

163.3

159.7

156.1

165.5

169.4

156.0

147.4

137.0

134.2

Prostate

170.1

171.9

174.0

171.7

156.6

153.0

149.4

158.9

162.8

149.2

140.7

130.4

127.6

Testis

5.4

5.4

5.5

5.3

5.5

5.6

5.6

5.5

5.6

5.7

5.6

5.6

5.5

Penis

0.9

0.9

0.9

0.9

0.9

0.8

0.8

0.8

0.9

0.9

0.8

0.8

0.9

Other male genital organs

0.2

0.3

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.3

0.2

0.2

0.2

Urinary system

35.4

35.9

36.3

36.7

37.2

37.9

38.3

38.2

38.5

38.6

38.3

37.3

36.8

Urinary bladder

22.2

22.2

22.1

22.1

22.1

22.4

22.3

21.6

21.7

21.5

21.4

20.8

20.4

Kidney and renal pelvis

12.3

12.8

13.4

13.8

14.3

14.7

15.2

15.8

15.9

16.2

16.1

15.7

15.6

Ureter

0.6

0.6

0.6

0.6

0.6

0.6

0.6

0.6

0.6

0.6

0.6

0.6

0.6

Other urinary organs

0.3

0.3

0.3

0.2

0.2

0.2

0.3

0.3

0.3

0.4

0.3

0.3

0.3

Eye and orbit

0.9

0.9

0.9

0.8

0.9

0.9

0.9

0.9

0.9

0.8

0.8

0.8

0.8

Brain and other nervous system

6.9

6.9

6.8

6.9

6.8

6.9

6.9

6.8

6.8

6.8

6.7

6.6

6.5

Brain

6.5

6.4

6.3

6.4

6.3

6.4

6.4

6.4

6.4

6.4

6.3

6.2

6.1

Cranial nerves other nervous system

0.5

0.5

0.5

0.4

0.5

0.5

0.5

0.4

0.5

0.5

0.4

0.4

0.4

Endocrine system

7.5

8.1

8.6

9.2

9.6

10.4

11.2

11.9

12.7

13.7

14.4

14.5

14.7

Thyroid

6.8

7.4

7.9

8.5

8.9

9.6

10.5

11.1

11.9

13.0

13.6

13.7

14.0

Other endocrine including thymus

0.7

0.7

0.7

0.7

0.7

0.8

0.7

0.8

0.8

0.8

0.7

0.8

0.7

Lymphomas

22.3

22.2

22.4

22.5

22.6

23.0

22.9

22.7

22.7

22.7

22.6

22.2

21.5

Hodgkin lymphoma

2.8

2.9

2.8

2.9

2.8

2.9

2.9

2.9

2.9

2.9

2.8

2.8

2.7

Non-Hodgkin lymphoma

19.4

19.3

19.5

19.6

19.8

20.2

20.0

19.8

19.8

19.8

19.8

19.4

18.8

Myeloma

5.6

5.8

5.9

5.9

5.9

6.0

6.0

5.9

5.9

6.0

6.1

6.1

6.1

Leukemias

13.0

13.4

13.6

13.2

13.4

13.5

13.3

13.4

13.1

13.1

13.0

13.4

13.1

Acute lymphocytic leukemia

1.4

1.5

1.5

1.5

1.5

1.6

1.5

1.6

1.6

1.7

1.6

1.6

1.7

Chronic lymphocytic leukemia

4.2

4.5

4.6

4.6

4.7

4.8

4.8

4.8

4.5

4.5

4.4

4.3

4.1

Acute myeloid leukemia

3.8

3.9

3.9

3.8

3.8

3.7

3.6

3.7

3.7

3.7

3.7

4.0

4.0

Chronic myeloid leukemia

1.6

1.7

1.7

1.6

1.6

1.6

1.6

1.6

1.6

1.6

1.7

1.7

1.7

Other leukemia

1.9

1.9

1.9

1.8

1.8

1.7

1.7

1.7

1.7

1.6

1.7

1.7

1.6

Mesothelioma

1.1

1.1

1.1

1.1

1.1

1.1

1.1

1.1

1.0

1.0

1.0

1.0

1.0

Kaposi Sarcoma

0.6

0.5

0.5

0.5

0.5

0.5

0.5

0.5

0.5

0.4

0.4

0.4

0.4

Miscellaneous

12.6

12.3

12.1

11.7

11.2

10.8

10.7

10.5

10.3

10.0

9.8

9.8

9.5

Abbreviation: NOS = not otherwise specified.

* Rates are the number of cases per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.

§ Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined for all years, 1999–2011 (covering approximately 89% of the U.S. population). See registry-specific data quality information for all years, 1999–2011 (available at http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_data_quality.htm). Caution should be used when comparing incidence and death rates because of potential differences in population coverage.


TABLE 14. Reported rate* of cancer deaths, by primary cancer site and year — United States, 1999–2011

Cancer site

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

All sites combined

200.7

198.8

196.3

194.4

190.9

186.8

185.2

182.0

179.3

176.3

173.4

171.8

168.7

Oral cavity and pharynx

2.7

2.7

2.7

2.7

2.6

2.6

2.5

2.5

2.5

2.5

2.4

2.5

2.5

Lip

0

0

0

0

0

0

0

0

0

0

0

0

0

Tongue

0.6

0.6

0.6

0.7

0.6

0.6

0.6

0.6

0.6

0.6

0.6

0.6

0.6

Salivary gland

0.2

0.2

0.2

0.3

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

Floor of mouth

0.1

0.1

0

0.1

0

0

0

0

0

0

0

0

0

Gum and other mouth

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.3

0.4

0.4

Nasopharynx

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

Tonsil

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

Oropharynx

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

Hypopharynx

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

Other oral cavity and pharynx

0.5

0.6

0.6

0.5

0.6

0.5

0.5

0.5

0.5

0.5

0.4

0.4

0.5

Digestive system

47.5

47.3

46.7

46.2

45.6

44.5

44.1

43.8

43.3

43.0

42.3

42.3

41.8

Esophagus

4.3

4.4

4.4

4.4

4.4

4.4

4.4

4.4

4.3

4.2

4.2

4.3

4.2

Stomach

4.6

4.5

4.4

4.3

4.2

4.0

3.8

3.7

3.6

3.5

3.4

3.4

3.3

Small intestine

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.3

0.4

0.4

0.4

0.4

Colon and rectum

20.9

20.7

20.2

19.8

19.1

18.1

17.6

17.3

16.9

16.5

15.8

15.5

15.1

Colon excluding rectum

17.9

17.6

17.1

16.8

16.2

15.2

14.7

14.4

14.1

13.6

13.0

12.6

12.3

Rectum and rectosigmoid junction

3.0

3.0

3.0

3.0

2.9

2.9

2.9

2.9

2.8

2.9

2.8

2.9

2.8

Anus, anal canal, and anorectum

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

Liver and intrahepatic bile duct

4.5

4.6

4.7

4.9

5.0

5.1

5.3

5.3

5.4

5.6

5.8

5.9

6.1

Gallbladder

0.8

0.7

0.7

0.7

0.7

0.7

0.7

0.7

0.6

0.6

0.6

0.6

0.6

Other biliary

0.6

0.6

0.6

0.5

0.5

0.5

0.5

0.5

0.5

0.4

0.4

0.5

0.4

Pancreas

10.6

10.5

10.6

10.6

10.5

10.7

10.8

10.9

10.8

11.0

10.8

11.0

10.9

Retroperitoneum

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

Peritoneum, omentum, and mesentery

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

Other digestive organs

0.4

0.3

0.3

0.3

0.3

0.2

0.2

0.3

0.3

0.3

0.3

0.3

0.3

Respiratory system

57.1

57.5

57.0

56.6

55.8

54.8

54.3

53.2

52.1

51.0

49.7

48.7

47.3

Nose, nasal cavity, and middle ear

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.1

0.2

0.2

0.2

0.1

0.1

Larynx

1.4

1.4

1.3

1.3

1.3

1.2

1.2

1.2

1.1

1.2

1.1

1.1

1.1

Lung and bronchus

55.4

55.8

55.3

55.0

54.2

53.4

52.9

51.7

50.7

49.6

48.4

47.4

46.0

Pleura

0

0

0

0

0

0

0

0

0

0

0

0

0

Trachea, mediastinum, and other respiratory organs

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

Bones and Joints

0.4

0.4

0.5

0.4

0.4

0.4

0.5

0.4

0.4

0.4

0.4

0.4

0.4

Soft tissue including heart

1.3

1.3

1.3

1.2

1.2

1.3

1.3

1.3

1.3

1.3

1.3

1.3

1.3

Skin excluding basal and squamous

3.5

3.5

3.5

3.4

3.5

3.5

3.6

3.6

3.6

3.5

3.7

3.6

3.6

Melanomas of the skin

2.6

2.7

2.7

2.6

2.7

2.7

2.8

2.7

2.7

2.7

2.8

2.7

2.7

Other nonepithelial skin

0.8

0.8

0.9

0.8

0.8

0.8

0.8

0.8

0.9

0.8

0.9

0.9

0.9

Male and female breast

15.2

15.2

14.8

14.5

14.3

13.8

13.6

13.2

12.9

12.7

12.4

12.3

12.0

Female beast

26.6

26.6

26.0

25.6

25.3

24.5

24.1

23.6

23.0

22.6

22.2

21.9

21.5

Male breast

0.3

0.4

0.4

0.3

0.3

0.3

0.3

0.3

0.3

0.3

0.3

0.3

0.3


TABLE 14. (Continued) Reported rate* of cancer deaths, by primary cancer site and year — United States, 1999–2011

Cancer site

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

Female genital system

16.7

16.7

16.8

16.7

16.4

16.2

16.0

16.1

15.8

15.5

15.2

15.5

15.3

Cervix

2.8

2.8

2.7

2.6

2.5

2.4

2.4

2.4

2.4

2.4

2.3

2.3

2.3

Corpus and uterus, NOS

4.1

4.1

4.2

4.2

4.1

4.1

4.1

4.2

4.2

4.2

4.2

4.5

4.5

Corpus

2.0

2.0

2.0

1.9

2.0

1.9

1.9

2.0

1.9

1.9

1.8

1.9

1.9

Uterus, NOS

2.1

2.1

2.2

2.2

2.2

2.2

2.2

2.2

2.3

2.3

2.4

2.5

2.6

Ovary

8.8

8.9

9.0

9.0

8.9

8.8

8.7

8.6

8.3

8.0

7.9

7.8

7.5

Vagina

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

Vulva

0.5

0.4

0.5

0.5

0.4

0.5

0.5

0.5

0.5

0.5

0.5

0.5

0.5

Other female genital organs

0.3

0.3

0.3

0.3

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.3

0.3

Male genital system

32.1

30.9

30.0

29.2

27.7

26.7

25.8

24.7

24.7

23.5

22.6

22.3

21.2

Prostate

31.6

30.4

29.5

28.7

27.2

26.2

25.4

24.2

24.2

23.0

22.1

21.8

20.8

Testis

0.3

0.2

0.2

0.3

0.2

0.3

0.2

0.2

0.2

0.2

0.3

0.3

0.3

Penis

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

0.2

Other male genital organs

0

0

0

0

0

0

0

0

0

0

0

0

0

Urinary system

8.7

8.8

8.8

8.9

8.7

8.8

8.8

8.7

8.7

8.6

8.5

8.6

8.6

Urinary bladder

4.4

4.3

4.3

4.4

4.3

4.4

4.4

4.4

4.4

4.4

4.4

4.4

4.4

Kidney and renal pelvis

4.1

4.2

4.3

4.2

4.2

4.1

4.1

4.0

4.0

4.0

3.9

3.9

3.9

Ureter

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

Other urinary organs

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

Eye and orbit

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

Brain and other nervous system

4.6

4.5

4.4

4.5

4.4

4.3

4.3

4.2

4.2

4.3

4.3

4.2

4.3

Endocrine system

0.8

0.8

0.8

0.8

0.7

0.8

0.8

0.8

0.8

0.8

0.8

0.8

0.8

Thyroid

0.5

0.5

0.5

0.5

0.4

0.5

0.5

0.5

0.5

0.5

0.5

0.5

0.5

Other endocrine including thymus

0.3

0.3

0.3

0.3

0.3

0.3

0.3

0.3

0.3

0.3

0.3

0.3

0.3

Lymphomas

8.8

8.6

8.4

8.1

7.8

7.5

7.4

7.2

7.0

6.8

6.7

6.5

6.4

Hodgkin lymphoma

0.5

0.5

0.5

0.5

0.5

0.4

0.4

0.4

0.4

0.4

0.4

0.4

0.4

Non-Hodgkin lymphoma

8.3

8.2

7.9

7.7

7.4

7.1

6.9

6.7

6.6

6.4

6.3

6.1

6.0

Myeloma

3.8

3.8

3.8

3.8

3.7

3.6

3.6

3.5

3.5

3.3

3.3

3.3

3.4

Leukemias

7.7

7.7

7.6

7.5

7.4

7.3

7.3

7.2

7.1

7.1

7.1

6.9

6.9

Acute lymphocytic leukemia

0.5

0.5

0.5

0.5

0.5

0.5

0.5

0.5

0.5

0.5

0.5

0.5

0.4

Chronic lymphocytic leukemia

1.6

1.6

1.6

1.6

1.5

1.5

1.5

1.5

1.4

1.4

1.4

1.4

1.4

Acute myeloid leukemia

2.5

2.7

2.7

2.8

2.8

2.8

2.8

2.8

2.8

2.8

2.9

2.8

2.8

Chronic myeloid leukemia

0.7

0.6

0.6

0.5

0.4

0.4

0.4

0.4

0.3

0.3

0.3

0.3

0.3

Other leukemia

2.4

2.3

2.2

2.2

2.2

2.2

2.2

2.1

2.1

2.1

2.0

2.0

2.0

Mesothelioma

0.9

0.9

0.8

0.9

0.9

0.9

0.9

0.8

0.8

0.8

0.8

0.8

0.8

Miscellaneous

16.2

14.8

14.4

14.4

14.0

13.5

13.4

13.0

12.7

12.4

12.2

11.9

11.7

Abbreviation: NOS = not otherwise specified.

* Rates are the number of deaths per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25-1130). For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).

Data are from the National Vital Statistics System (NVSS). Data for deaths cover 100% of the U.S. population. Caution should be used when comparing incidence and death rates because of potential differences in population coverage.


TABLE 15. Reported number of invasive* cancer cases by primary site and year — United States, 1999–2011

Cancer site

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

All sites combined

1,180,100

1,201,031

1,224,220

1,234,500

1,228,017

1,245,608

1,265,769

1,295,571

1,329,613

1,342,306

1,352,526

1,337,067

1,347,590

Oral cavity and pharynx

26,367

26,750

27,080

27,687

28,203

28,794

29,055

29,936

31,413

32,725

33,069

33,667

34,859

Lip

2,320

2,265

2,204

2,173

1,938

1,856

1,744

1,759

1,793

1,774

1,744

1,810

1,749

Tongue

6,383

6,607

6,759

7,198

7,421

7,808

7,955

8,374

9,028

9,687

9,756

9,796

10,556

Salivary gland

2,855

3,003

3,056

3,103

3,171

3,223

3,331

3,466

3,469

3,599

3,610

3,574

3,574

Floor of mouth

2,004

1,965

1,991

1,932

1,857

1,853

1,765

1,849

1,839

1,856

1,840

1,843

1,734

Gum and other mouth

4,193

4,006

4,132

4,041

4,178

4,159

4,158

4,185

4,351

4,531

4,441

4,594

4,679

Nasopharynx

1,417

1,475

1,361

1,471

1,550

1,506

1,559

1,509

1,647

1,646

1,540

1,582

1,533

Tonsil

3,251

3,443

3,638

3,890

4,149

4,400

4,590

4,851

5,116

5,504

6,003

6,076

6,439

Oropharynx

943

1,001

1,038

1,053

1,211

1,231

1,238

1,309

1,347

1,406

1,388

1,578

1,632

Hypopharynx

2,106

2,049

1,992

1,982

2,044

2,049

2,026

1,951

2,040

1,980

2,037

1,967

2,033

Other oral cavity and pharynx

895

936

909

844

684

709

689

683

783

742

710

847

930

Digestive system

223,637

226,849

229,051

230,027

232,820

234,283

234,990

236,554

239,302

242,028

241,931

239,635

240,813

Esophagus

12,162

12,357

12,552

12,568

13,046

13,615

13,474

13,945

13,929

14,486

14,575

13,960

14,225

Stomach

18,617

18,563

18,458

18,763

18,988

18,971

18,684

18,714

19,095

18,920

19,328

20,082

20,122

Small intestine

4,115

4,125

4,439

4,690

4,834

5,156

5,416

5,702

5,913

6,243

6,388

6,766

6,755

Colon and rectum

137,463

138,543

138,331

137,243

136,306

134,550

133,145

131,461

130,770

129,645

125,959

121,725

120,704

Colon excluding rectum

100,240

101,114

101,110

100,385

99,524

97,993

96,392

95,393

94,621

93,769

90,390

87,118

86,352

Rectum and rectosigmoid junction

37,223

37,429

37,221

36,858

36,782

36,557

36,753

36,068

36,149

35,876

35,569

34,607

34,352

Anus, anal canal, and anorectum

3,335

3,406

3,506

3,663

4,030

4,143

4,329

4,343

4,789

4,988

5,386

5,194

5,409

Liver and intrahepatic bile duct

12,032

12,918

13,043

13,910

14,725

15,918

16,778

17,856

19,367

20,440

22,251

22,820

23,582

Gallbladder

2,996

2,884

3,040

2,887

3,013

3,042

3,130

3,164

3,176

3,209

3,419

3,396

3,437

Other Biliary

3,242

3,450

4,072

4,246

4,405

4,477

4,513

4,691

4,715

4,979

5,138

5,201

5,382

Pancreas

26,920

27,697

28,325

28,653

29,883

30,660

31,666

32,783

33,536

34,956

35,424

36,382

36,935

Retroperitoneum

948

922

989

1,029

998

1,022

1,081

1,035

1,065

1,087

1,073

1,099

1,162

Peritoneum, omentum, and mesentery

1,078

1,152

1,336

1,410

1,588

1,730

1,728

1,679

1,808

1,880

1,749

1,723

1,742

Other digestive organs

729

832

960

965

1,004

999

1,046

1,181

1,139

1,195

1,241

1,287

1,358

Respiratory system

185,613

186,395

188,513

190,434

193,054

193,826

197,824

198,575

200,014

201,809

202,265

198,756

196,160

Nose, nasal cavity, and middle ear

1,726

1,723

1,688

1,799

1,728

1,865

1,893

1,874

2,031

1,987

2,003

1,906

1,919

Larynx

11,199

11,013

10,930

10,596

10,749

10,903

10,859

10,950

10,934

10,938

10,959

11,083

10,698

Lung and bronchus

172,056

173,025

175,351

177,462

179,983

180,442

184,457

185,147

186,425

188,212

188,668

185,113

182,967

Pleura

101

99

75

93

83

92

86

80

95

90

99

100

90

Trachea, mediastinum, and other respiratory organs

531

535

469

484

511

524

529

524

529

582

536

554

486

Bones and joints

2,371

2,350

2,528

2,523

2,459

2,515

2,628

2,587

2,645

2,564

2,704

2,593

2,620

Soft tissue including heart

7,024

7,373

7,521

7,659

8,048

8,426

8,670

8,518

9,083

9,165

9,269

9,544

9,334

Skin excluding basal and squamous

40,502

43,910

47,160

48,686

49,042

52,200

56,024

56,201

58,305

60,717

62,538

61,969

63,522

Melanomas of the skin

37,269

40,351

43,356

44,856

45,104

48,151

51,794

51,959

53,833

55,902

57,635

57,295

58,776

Other nonepithelial skin

3,233

3,559

3,804

3,830

3,938

4,049

4,230

4,242

4,472

4,815

4,903

4,674

4,746

Male and female breast

180,390

179,961

182,086

180,754

174,289

175,389

177,766

181,643

186,751

191,457

196,283

192,592

198,294

Female breast

178,998

178,555

180,748

179,334

172,808

173,840

176,249

180,053

185,098

189,666

194,519

190,741

196,459

Male breast

1,392

1,406

1,338

1,420

1,481

1,549

1,517

1,590

1,653

1,791

1,764

1,851

1,835


TABLE 15. (Continued) Reported number of invasive* cancer cases by primary site and year — United States, 1999–2011

Cancer site

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

Female genital system

68,956

69,595

70,434

69,879

69,141

70,251

71,732

72,837

74,498

76,257

77,839

78,049

79,194

Cervix

12,482

12,492

11,952

11,535

11,225

11,043

11,247

11,220

11,239

11,169

11,311

10,901

10,805

Corpus and uterus, NOS

32,271

32,402

33,588

33,764

33,095

34,620

35,626

36,471

37,820

39,290

40,907

41,652

42,821

Corpus

31,204

31,310

32,479

32,654

32,007

33,524

34,499

35,389

36,737

38,028

39,555

40,358

41,459

Uterus, NOS

1,067

1,092

1,109

1,110

1,088

1,096

1,127

1,082

1,083

1,262

1,352

1,294

1,362

Ovary

19,144

19,557

19,633

19,258

19,440

19,088

19,296

19,381

19,328

19,509

19,054

18,681

18,497

Vagina

977

1,033

1,023

1,045

1,002

1,063

953

1,050

1,052

1,073

1,101

1,109

1,108

Vulva

3,265

3,213

3,337

3,309

3,427

3,445

3,571

3,643

3,829

3,855

4,002

4,025

4,126

Other female genital organs

817

898

901

968

952

992

1,039

1,072

1,230

1,361

1,464

1,681

1,837

Male genital system

187,393

192,546

198,441

200,398

187,837

188,068

188,321

205,010

216,720

206,126

201,601

192,722

194,358

Prostate

179,466

184,476

190,274

192,390

179,550

179,737

179,824

196,614

208,130

197,225

192,875

183,941

185,622

Testis

6,709

6,823

6,936

6,769

7,021

7,126

7,253

7,119

7,263

7,414

7,375

7,387

7,267

Penis

966

976

964

986

1,000

943

960

979

1,063

1,161

1,063

1,092

1,149

Other male genital organs

252

271

267

253

266

262

284

298

264

326

288

302

320

Urinary system

86,075

88,718

90,945

93,415

96,512

99,897

102,660

104,202

107,184

109,862

111,221

110,512

111,380

Urinary bladder

53,970

54,941

55,237

56,070

57,154

58,678

59,510

58,567

60,131

60,866

61,682

61,273

61,428

Kidney and renal pelvis

29,927

31,631

33,517

35,211

37,189

39,015

40,909

43,250

44,631

46,373

47,024

46,758

47,384

Ureter

1,491

1,476

1,513

1,503

1,529

1,566

1,546

1,649

1,616

1,632

1,663

1,630

1,671

Other urinary organs

687

670

678

631

640

638

695

736

806

991

852

851

897

Eye and orbit

2,118

2,182

2,195

2,168

2,347

2,358

2,336

2,401

2,407

2,391

2,418

2,282

2,289

Brain and other nervous system

16,919

17,128

17,105

17,531

17,621

18,139

18,281

18,457

18,705

19,007

19,122

18,924

18,883

Brain

15,811

15,962

15,934

16,393

16,356

16,877

17,013

17,286

17,468

17,766

17,889

17,775

17,763

Cranial nerves other nervous system

1,108

1,166

1,171

1,138

1,265

1,262

1,268

1,171

1,237

1,241

1,233

1,149

1,120

Endocrine system

18,320

20,187

21,691

23,410

24,760

27,179

29,817

31,971

34,652

37,948

40,141

40,904

42,106

Thyroid

16,689

18,526

19,898

21,623

22,906

25,204

27,849

29,946

32,531

35,749

38,045

38,753

40,082

Other endocrine including thymus

1,631

1,661

1,793

1,787

1,854

1,975

1,968

2,025

2,121

2,199

2,096

2,151

2,024

Lymphomas

54,407

54,956

56,164

57,396

58,653

60,539

61,251

61,497

62,619

63,766

64,549

64,682

63,858

Hodgkin lymphoma

7,025

7,169

7,098

7,385

7,329

7,447

7,701

7,625

7,663

7,929

7,694

7,717

7,486

Non-Hodgkin lymphoma

47,382

47,787

49,066

50,011

51,324

53,092

53,550

53,872

54,956

55,837

56,855

56,965

56,372

Myeloma

13,625

14,238

14,686

14,958

15,283

15,785

16,178

16,240

16,447

17,238

17,834

18,145

18,508

Leukemias

31,635

33,283

34,166

33,587

34,659

35,236

35,317

36,172

36,108

36,588

37,144

38,851

38,623

Acute lymphocytic leukemia

3,553

3,702

3,830

3,795

3,848

4,003

3,941

4,141

4,249

4,370

4,334

4,437

4,520

Chronic lymphocytic leukemia

10,169

11,065

11,627

11,730

12,160

12,600

12,917

13,083

12,603

12,742

12,725

12,741

12,646

Acute myeloid leukemia

9,237

9,751

9,846

9,561

9,793

9,757

9,618

9,929

10,029

10,338

10,468

11,665

11,724

Chronic myeloid leukemia

4,011

4,143

4,210

3,956

4,156

4,313

4,217

4,426

4,426

4,554

4,792

4,964

4,915

Other leukemia

4,665

4,622

4,653

4,545

4,702

4,563

4,624

4,593

4,801

4,584

4,825

5,044

4,818

Mesothelioma

2,730

2,798

2,793

2,815

2,830

2,866

2,975

2,891

2,848

2,902

2,930

2,933

2,922

Kaposi Sarcoma

1,361

1,353

1,346

1,252

1,306

1,277

1,320

1,180

1,218

1,142

1,133

1,051

1,068

Miscellaneous

30,657

30,459

30,315

29,921

29,153

28,580

28,624

28,699

28,694

28,614

28,535

29,256

28,799

Abbreviation: NOS = not otherwise specified.

* Invasive cancer excludes basal and squamous cell carcinomas of the skin except when these occur on the skin of the genital organs, and in situ cancers except urinary bladder. Urinary bladder cancer includes invasive and in situ.

Data are compiled from cancer registries that meet the data quality criteria for all invasive cancer sites combined for all years, 1999–2011 (covering approximately 89% of the U.S. population). See registry-specific data quality information for all years, 1999–2011 (available at http://www.cdc.gov/cancer/npcr/uscs/2011/data/00_data_quality.htm). Caution should be used when comparing number of cases and deaths because of potential differences in population coverage.


TABLE 16. Reported number of cancer deaths, by primary cancer site and year — United States, 1999–2011*

Cancer site

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

All sites combined

549,829

553,080

553,760

557,264

556,890

553,880

559,303

559,880

562,867

565,460

567,614

574,738

576,685

Oral cavity and pharynx

7,486

7,492

7,701

7,737

7,777

7,826

7,773

7,720

8,067

8,019

7,922

8,474

8,657

Lip

52

67

77

74

72

74

60

51

66

68

57

69

83

Tongue

1,738

1,767

1,818

1,887

1,875

1,881

1,948

1,906

2,034

1,983

1,971

2,125

2,089

Salivary gland

656

663

685

722

696

697

701

699

742

718

795

827

820

Floor of mouth

180

153

135

149

147

122

135

114

102

99

109

93

84

Gum and other mouth

1,215

1,213

1,179

1,152

1,176

1,168

1,118

1,108

1,109

1,160

1,091

1,212

1,245

Nasopharynx

638

650

621

628

598

637

615

633

677

645

662

701

630

Tonsil

543

518

612

638

608

592

647

654

688

724

736

795

842

Oropharynx

600

547

592

606

626

658

655

650

721

734

720

806

861

Hypopharynx

385

359

348

323

318

368

281

301

324

294

279

324

322

Other oral cavity and pharynx

1,479

1,555

1,634

1,558

1,661

1,629

1,613

1,604

1,604

1,594

1,502

1,522

1,681

Digestive system

130,070

131,455

131,726

132,541

133,010

132,215

133,562

135,140

136,419

138,469

139,200

142,680

144,007

Esophagus

11,917

12,232

12,529

12,700

12,860

13,023

13,499

13,685

13,592

13,714

13,908

14,490

14,446

Stomach

12,711

12,645

12,319

12,198

12,110

11,859

11,514

11,345

11,388

11,352

11,184

11,390

11,035

Small intestine

1,036

1,057

1,082

1,017

1,070

1,115

1,117

1,091

1,083

1,192

1,195

1,218

1,256

Colon and rectum

57,222

57,434

56,808

56,603

55,783

53,580

53,005

53,196

53,219

52,857

51,848

52,045

51,783

Colon excluding rectum

48,962

49,019

48,292

47,987

47,248

44,988

44,325

44,331

44,247

43,650

42,471

42,245

42,181

Rectum and rectosigmoid junction

8,260

8,415

8,516

8,616

8,535

8,592

8,680

8,865

8,972

9,207

9,377

9,800

9,602

Anus, anal canal, and anorectum

462

492

511

539

555

589

583

623

644

718

818

813

863

Liver and intrahepatic bile duct

12,382

12,916

13,351

14,047

14,706

15,321

16,075

16,525

17,146

18,213

19,352

20,304

21,608

Gallbladder

2,059

1,949

1,971

1,907

1,915

1,936

1,989

2,000

1,914

1,971

2,048

2,105

2,101

Other biliary

1,531

1,717

1,630

1,501

1,491

1,461

1,464

1,427

1,436

1,377

1,384

1,519

1,510

Pancreas

29,081

29,331

29,802

30,263

30,777

31,771

32,759

33,454

34,117

35,234

35,628

36,888

37,344

Retroperitoneum

220

262

220

219

191

219

238

190

204

226

186

202

219

Peritoneum, omentum, and mesentery

429

503

543

616

602

686

648

698

721

695

703

702

807

Other digestive organs

1,020

917

960

931

950

655

671

906

955

920

946

1,004

1,035

Respiratory system

156,708

160,051

160,602

162,148

162,589

162,400

163,751

163,134

163,065

163,141

162,492

162,730

161,376

Nose, nasal cavity, and middle ear

456

419

485

444

457

458

484

426

475

516

530

495

416

Larynx

3,815

3,861

3,797

3,722

3,791

3,668

3,796

3,821

3,634

3,760

3,630

3,691

3,732

Lung and bronchus

152,061

155,426

155,969

157,630

157,990

158,006

159,217

158,599

158,683

158,592

158,081

158,248

156,953

Pleura

99

76

84

73

76

78

67

64

48

54

55

54

61

Trachea, mediastinum, and other respiratory organs

277

269

267

279

275

190

187

224

225

219

196

242

214

Bones and joints

1,224

1,212

1,298

1,194

1,262

1,301

1,391

1,340

1,362

1,357

1,384

1,378

1,423

Soft tissue including heart

3,679

3,693

3,646

3,554

3,651

3,722

3,849

3,960

4,023

4,093

4,229

4,376

4,408

Skin excluding basal and squamous

9,530

9,672

9,992

9,904

10,214

10,301

10,798

11,068

11,234

11,337

12,130

12,089

12,212

Melanomas of the skin

7,215

7,420

7,542

7,513

7,818

7,952

8,345

8,441

8,461

8,623

9,199

9,154

9,128

Other nonepithelial skin

2,315

2,252

2,450

2,391

2,396

2,349

2,453

2,627

2,773

2,714

2,931

2,935

3,084

Male and female breast

41,528

42,300

41,809

41,883

41,998

41,316

41,491

41,209

40,969

41,026

41,076

41,435

41,374

Female breast

41,144

41,872

41,394

41,514

41,619

40,954

41,116

40,820

40,598

40,589

40,676

40,996

40,931

Male breast

384

428

415

369

379

362

375

389

371

437

400

439

443


TABLE 16. (Continued) Reported number of cancer deaths, by primary cancer site and year — United States, 1999–2011*

Cancer site

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

Female genital system

25,881

26,411

26,838

27,091

27,011

27,049

27,259

27,848

27,739

27,813

27,817

28,770

29,027

Cervix

4,204

4,200

4,092

3,952

3,919

3,850

3,924

3,976

4,021

4,008

3,909

3,939

4,092

Corpus and uterus, NOS

6,468

6,585

6,783

6,853

6,899

6,990

7,096

7,384

7,456

7,675

7,713

8,402

8,641

Corpus

3,121

3,139

3,185

3,187

3,261

3,272

3,259

3,449

3,377

3,436

3,333

3,644

3,714

Uterus, NOS

3,347

3,446

3,598

3,666

3,638

3,718

3,837

3,935

4,079

4,239

4,380

4,758

4,927

Ovary

13,627

14,060

14,414

14,682

14,657

14,716

14,787

14,857

14,621

14,362

14,436

14,572

14,346

Vagina

403

405

382

378

391

416

382

396

376

417

398

423

428

Vulva

762

752

765

794

775

806

809

862

865

921

946

942

1,022

Other female genital organs

417

409

402

432

370

271

261

373

400

430

415

492

498

Male genital system

32,349

31,675

31,300

31,084

30,176

29,627

29,514

29,022

29,703

29,120

28,744

29,276

28,630

Prostate

31,728

31,078

30,719

30,446

29,554

29,002

28,905

28,372

29,093

28,471

28,088

28,560

27,970

Testis

378

338

335

393

344

357

359

358

326

358

376

399

380

Penis

202

217

205

209

250

231

217

245

246

246

234

258

239

Other male genital organs

41

42

41

36

28

37

33

47

38

45

46

59

41

Urinary system

23,666

24,344

24,910

25,443

25,422

25,928

26,404

26,649

27,319

27,682

27,941

28,726

29,317

Urinary bladder

11,910

12,002

12,225

12,627

12,483

13,030

13,253

13,474

13,843

14,036

14,201

14,730

15,014

Kidney and renal pelvis

11,116

11,736

12,078

12,165

12,286

12,313

12,517

12,379

12,703

12,895

12,995

13,219

13,559

Ureter

345

302

294

297

323

334

347

361

340

354

371

350

338

Other urinary organs

295

304

313

354

330

251

287

435

433

397

374

427

406

Eye and orbit

227

236

226

240

231

208

252

219

249

262

278

283

280

Brain and other
nervous system

12,765

12,655

12,609

12,830

12,901

12,829

13,152

12,886

13,234

13,724

14,176

14,164

14,491

Endocrine system

2,146

2,210

2,299

2,231

2,155

2,272

2,354

2,404

2,488

2,555

2,634

2,641

2,689

Thyroid

1,241

1,328

1,354

1,367

1,312

1,409

1,462

1,518

1,562

1,649

1,707

1,686

1,747

Other endocrine including thymus

905

882

945

864

843

863

892

886

926

906

927

955

942

Lymphomas

24,205

24,016

23,628

23,262

22,822

22,214

22,145

21,920

21,799

21,539

21,639

21,525

21,485

Hodgkin lymphoma

1,403

1,287

1,323

1,352

1,347

1,276

1,272

1,327

1,271

1,171

1,250

1,231

1,168

Non-Hodgkin lymphoma

22,802

22,729

22,305

21,910

21,475

20,938

20,873

20,593

20,528

20,368

20,389

20,294

20,317

Myeloma

10,508

10,639

10,714

10,913

10,809

10,578

10,758

10,712

10,872

10,606

10,690

11,022

11,411

Leukemias

21,071

21,397

21,532

21,581

21,608

21,472

21,716

22,016

21,928

22,431

22,688

22,673

23,194

Acute lymphocytic leukemia

1,361

1,395

1,433

1,432

1,429

1,371

1,460

1,393

1,418

1,424

1,423

1,436

1,432

Chronic lymphocytic leukemia

4,476

4,323

4,386

4,443

4,476

4,342

4,391

4,498

4,471

4,395

4,557

4,486

4,608

Acute myeloid leukemia

6,932

7,413

7,749

7,914

8,126

8,214

8,267

8,539

8,568

8,962

9,223

9,150

9,491

Chronic myeloid leukemia

1,788

1,802

1,649

1,367

1,233

1,164

1,067

1,077

984

1,000

1,003

1,019

1,091

Other leukemia

6,514

6,464

6,315

6,425

6,344

6,381

6,531

6,509

6,487

6,650

6,482

6,582

6,572

Mesothelioma

2,343

2,384

2,371

2,430

2,476

2,504

2,553

2,452

2,432

2,538

2,606

2,574

2,651

Miscellaneous

44,401

41,176

40,519

41,144

40,723

40,070

40,534

40,140

39,920

39,700

39,926

39,886

40,002

Abbreviation: NOS = not otherwise specified.

* Data are from the National Vital Statistics System (NVSS). Data for deaths cover 100% of the U.S. population. Caution should be used when comparing numbers of cases and deaths because of potential differences in population coverage. For more information, see USCS technical notes (available at http://www.cdc.gov/cancer/npcr/uscs/2011/technical_notes).



Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.


All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #